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Background 
 Sjögren’s syndrome (SS) is an autoimmune disorder that primarily targets 
the salivary and lacrimal glands, leading to the dryness of the mouth and 
eyes. Aquaporins (AQPs) are small hydrophobic transmembrane water 
channel proteins that are widely expressed in animals and plants as well as in 
bacteria and archaea. The expressions of mRNA and proteins for AQP5 and 
AQP1 have been shown in human salivary glands. AQP5 is expressed at the 
apical membrane of acinar cells and intercalated ducts in the lacrimal and 
salivary glands, while AQP1 expression is confined to the capillary 
endothelial and myoepithelial cells. AQP5 plays an important role in the 




substantially reduced volume. AQPs, porins, or glycerol transport proteins of 
some oral bacteria have a high degree of homology with human AQP5 and 
AQP1. B cell epitope analysis showed the presence of evolutionary 
conserved linear epitopes in the extracellular loops of humans AQP5/1 and 
the bacterial porins, suggesting a possibility that antibodies produced against 
the bacterial porins may cross react with the extracellular loops of human 
AQP5/1 and block the entry of water molecules into the channel.  
Growing evidence also suggests that dysbiosis of microbiota is associated 
with pathogenesis of several autoimmune diseases. However, the role of oral 
microbiota in the etiopathogenesis of SS in not known. The purpose of this 
study was to investigate the potential role of autoantibodies against human 
AQP5 and AQP1 and oral microbiota in the pathogenesis of SS. 
Material and methods  
Frozen sections of mouse submandibular salivary glands, Chinese hamster 
ovary (CHO) cells overexpressing green fluorescent protein (GFP) alone or 
human AQP5-GFP as a fusion protein, and Madin-darby canine kidney cells 
(MDCK) overexpressing AQP5 or AQP1 were used in the indirect 
immunofluorescence assay (IIFA) to detect anti-AQP5/1 autoantibodies in 
the sera from patients with primary SS. The lysates of human embryonic 




GFP alone were used for immunoprecipitation. Synthetic peptides 
corresponding to the extracellular loops of human-AQP5 were used to map 
the epitopes of AQP5. The communities of oral bacteria from healthy control 
(HC), patients with dry mouth due to medication as sicca control (SC) and 
SS patients were analyzed by pyrosequencing. Human salivary gland (HSG) 
cells were infected with selected oral bacteria to examine the bacterial 
invasion and expression of cytokines and chemokines. C57BL/6 mice were 
randomly divided into four groups (n=5 per group); Sham, Fn, Pm and Fn-
Pm groups. Fn, Pm, Fn-Pm groups were sublingually inoculated six times 
with 2x10
9
 cells of F. nucleatum (Fn), P. melaninogenica (Pm), and Fn plus 
Pm together, respectively, The pilocarpine stimulated salivary flow rate of 
each mice was measured at two weeks interval. Mouse salivary glands 
collected for histopathology and mRNA extraction to analyze the expression 
of cytokines/chemokines. Sera were used to detect anti-AQP5 autoantibodies. 
Results  
Serum IgG from the SS patients, but not from the control subjects, stained 
acinar cells in the mouse salivary glands, the signals of which colocalized 
with those of AQP5-specific antibodies. Serum IgG from the SS patients also 
selectively stained AQP5-GFP expressed in CHO cells. However, both the 
control and SS sera immunoprecipitated the AQP5-GFP in protein lysate, 




sera. The screening of 53 control and 112 SS serum samples by IIFA using 
the AQP5-expressing MDCK cells revealed the presence of significantly 
higher levels of anti-AQP5 IgG in the SS samples than in the control samples 
with sensitivity of 0.73 and a specificity of 0.68. Anti-AQP1 autoantibodies 
were also detected only in the 16.07% SS samples. Furthermore, the 
presence of anti-AQP5 autoantibodies, but not that of anti-AQP1 
autoantibodies, was associated with low resting salivary flow in SS patients. 
Synthetic peptides corresponding to the extracellular loops of AQP5 
significantly inhibited the binding of anti-AQP5 autoantibodies in the SS 
samples to MDCK-AQP5 cells. Pyrosequencing data revealed drastic 
changes in the bacterial communities associated with the dryness of mouth. 
Although the bacterial communities of SC and SS were similar to each other, 
the relative abundance of species/phylotypes were different between SC and 
SS. Logistic regression analysis revealed that Pm was associated with 
increased SS risk (OR 5.396 per 1% increase, CI 95% 1.793-16.238, 
p=0.003). Pm and Fn were chosen for in-vitro and in-vivo experiments 
because Pm has a porin with high homology to AQP5 and Fn has high 
invasive ability among the several oral species with known invasive 
capabilities. HSG cells produced the high levels of proinflammatory cytokine 
IL-6 and C-X-C motif chemokine ligand (CXCL)-10 in response to Fn but 




Fn and Pm into C57BL/6 mice produced sicca symptoms with mild 
recruitment of T cells to the salivary gland tissues in a few mice. 
Conclusion 
In conclusion, autoantibodies to human AQP5 and altered oral microbiota 
may contribute to the etiopathogenesis of SS.  Anti-AQP5 autoantibodies 
detected in the sera from SS patients may be a novel biomarker of SS and 
may provide new insight into the pathogenesis of SS. 
           
Keywords: Sjögren’s syndrome, autoantibodies, AQP5, AQP1, 
Pyrosequencing analysis  
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SS is an autoimmune disorder that primarily targets the salivary and lacrimal 
glands, leading to dryness of the mouth and eyes (Nikolov & Illei, 2009). In 
addition to glandular dysfunction, SS patients often present with 
extraglandular manifestation, such as tubulointerstitial nephritis (Maripuri et 
al., 2009), primary biliary cirrhosis, autoimmune cholangitis, autoimmune 
hepatitis (Kaplan & Ike, 2002), interstitial lung disease, development of 
lymphocytic malignancies (Bournia & Vlachoyiannopoulos, 2012; Parambil 
et al., 2006; Shen et al., 2012; Tzioufas et al., 2012), and serological 
abnormalities (Luciano et al., 2015). The disease is named after a Swedish 
ophthalmologist Heniky Sjögren who first described the clinical features in 
1933. 
SS is classified into two distinct forms: 
 Primary SS: characterized by dryness of mouth and eyes without an 
association with other autoimmune diseases, with population 
prevalence of 0.1-0.5% and a female preponderance (female to male 
ratio is 9:1). The primary SS has two age peaks, the first after 





 Secondary SS: characterized by dryness of mouth and eyes 
associated with other autoimmune disorders e.g. rheumatoid arthritis 
(RA), systemic lupus erythematosus (SLE), and progressive systemic 
sclerosis (PSS). Ocular symptoms are more prevalent than oral 
symptoms in secondary SS.  
1.1. Revised international diagnosis criteria for SS  
For diagnosis of SS the following criteria must be met; (Vitali et al., 2002). 
I. Ocular symptoms (at least one)  
 Symptoms of dry eyes ( at least 3 months) 
 Foreign body sensation 
 Use of artificial tear ( 3 or more time per day) 
II. Oral symptoms (at least one) 
 Symptoms of dry mouth (at least 3 months) 
 Swollen salivary glands 
 Need of liquid to swallow food 
III. Ocular signs (at least one) 
 Abnormal Schirmer’s test  









V. Oral signs (at least one) 
 Unstimulated whole salivary flow (< 1.5 ml in 15min) 
 Abnormal parotid sialography 
 Abnormal salivary scintigraphy 
VI. Autoantibodies (at least one) 
 Anti-Ro or Anti-La or both 
Revised rules for diagnosis as primary SS 
 Any 4 of the 6 criteria, must include either histopathology or 
autoantibodies  
 Any 3 of the 4 objective criteria (III, IV, V, VI) 
Revised rules for diagnosis as secondary SS    
Patients with well-defined major connective tissue disease, the presence of 
one symptom (I or II) plus 2 of the 3 objective criteria (III, IV and V) is 
indicative of secondary SS.  
Exclusion criteria:  
 Past head and neck radiation treatment  




 Acquired immunodeficiency disease (AIDS) 
 Pre-existing lymphoma  
 Sarcoidosis 
 Graft versus host disease 
 Use of anticholinergic drugs  
1.2. Pathogenesis of SS 
SS is a multifactorial autoimmune disease; both environmental and hormonal 
factors trigger exocrinopathy in individuals with genetic predisposition. 
These factors are discussed as follows: 
 Genetic factors  
 Hormonal factors  
 Environmental factors  
 Role of epithelial cells 
1.2.1. Genetic factors  
Traditionally, genetic predisposition has been implicated in the development 
of SS. Family members of SS patients have a higher incidence of SS and 
other autoimmune diseases than do age and sex  match control group (Kuo et 
al., 2015). Strong association with several human leukocytes antigens (HLA) 
molecules includes HLA-DR, HLA-DQB1, and HLA-DQA1 as well as 




and signal transducer and activator of transcription factor (STAT) 4 has been 
established (Lessard et al., 2013; Voulgarelis & Tzioufas, 2010). However, 
none of these associations exceeded the genome wide significance (GWS) 
threshold of P=5*10
-8
 (Lessard et al., 2013; Luciano et al., 2015; Tzioufas et 
al., 2012). According to the current literature other genetic factors increasing 
the risk for developing SS includes; natural cytotoxicity triggering receptor 3 
(NCR3), polymorphism in B-lymphocyte kinase (Blk), early B cell factor 1 
(EBF1), TNFAIP3-interacting protein 1 (TNIP1), lymphotoxin gene A 
(LTA), chemokine ligand 11 (Nezos & Mavragani, 2015).  
1.2.2. Hormonal factors 
The strong female predominance especially in postmenopausal women and 
result from many animal models has indicated the role of estrogen deficiency 
in SS (Konttinen et al., 2012). Studies have shown the presence of estrogen 
receptor (ER) and ER mRNA in salivary gland tissues (Kassi et al., 2003). In 
murine experimental model, estrogen can ameliorate T cells recruitment and 
prevent cell death in salivary gland (Lee et al., 2012). Aromatase (estrogen 
synthetase) deficient mice develop lymphocytic exocrinopathy resembling 
SS (Shim et al., 2004). Salivary epithelial cells from estrogen deficient mice 
function as antigen presenting cells upregulates the expression of major 
histocompatibility complex (MHC) class II molecules, IFN-and interleukin 




cells to present autoantigen to the CD4
+
 T cells results in the development of 
SS like lesions in salivary gland (Tzioufas et al., 2012; Voulgarelis & 
Tzioufas, 2010). On the other hand, estrogen prevents apoptosis of salivary 
gland epithelial cells as well as inhibits the IFN- induced intercellular 
adhesion molecule (ICAM)-1 expression as adhesive molecule indicative of 
cellular activation (Mavragani et al., 2012).  
1.2.3. Environmental factors  
Among the environmental factors, viral infections particularly 
cytomegalovirus (CMV), Epstein-Barr virus (EBV), HCV, retroviral 
elements, human herpes virus types 6 (HHV6), and human T lymphotropic 
virus type I (HTLV-I) has been suspected as triggering factor for SS in 
patients with genetic predisposition (Triantafyllopoulou & Moutsopoulos, 
2007). Although the association between SS and virus infections is still 
unclear, high incidence rate of EBV reactivation in the salivary glands of SS 
patients suggests the role of EBV in the initiation or perpetuation of immune 
response towards the salivary gland (Fox et al., 1991; Toda et al., 1994). The 
immune responses in the salivary gland that are characterized by type-I IFN 
signature, including the overexpression of type I IFN inducible genes, such 
as IFN-stimulated transcription factor-3(ISGF3G) and IFN-induced 




in SS (Luciano et al., 2015; Tzioufas et al., 2012; Voulgarelis & Tzioufas, 
2010). 
 
Cellular and molecular pathways implicated in the pathogenesis of SS 
(Re-drawn diagram adopted from; Nat. Rev. Rheumatol. 
doi:10.1038/nrrheum.2010.118) 
 
1.2.4. Role of epithelial cells  
Although salivary gland cells are never shown to act as antigen presenting 
cells, but their enhanced expression of MHC class-I (HLA-ABC) and class-II 
(HLA-DR) molecules, ICAM-1, vascular cell adhesion molecule (VCAM) 1, 
E-selectin adhesion molecules, costimulatory molecules such as CD40, 
CD80 (B7-1) and CD86 (B7-2) (Tsunawaki et al., 2002), increased 




factor (TNF) several T cell attracting and germinal center forming 
chemokines (Voulgarelis & Tzioufas, 2010) as well as B cells activating 
factor (BAFF) show their potential role in the accumulation of dendritic cells 
(DCs), T cells and B cells in the salivary gland of SS patient and the 
formation of lymphoid tissue (Manoussakis & Kapsogeorgou, 2007). 
Recently it has been shown that SS acinar epithelial cells express increased 
apoptosis regulator BAX and undergoes apoptosis, while infiltrating 
lymphocytes express Bcl-2 and are resistance to apoptosis which prolonged 
their survival. Through apoptosis and exosome formation, epithelial cells 
present intracellular autoantigen which results in loss of immune tolerance 
(Kapsogeorgou et al., 2005). Epithelial cells not only present the 
autoantigens but also concomitantly activate B cells by local secretin of 
BAFF (Luciano et al., 2015; Manoussakis & Kapsogeorgou, 2007; 





Role of epithelial cells in autoimmune reaction in SS 
(Re-drawn diagram adopted from; Clinic Rev Allerg Immunol 2007; 32:225–230) 
1.3. Mechanisms for salivary gland secretory dysfunction  
Glandular dysfunction had been understood as a result of apoptotic 
destruction of acinar cells by infiltrated cytotoxic T cells because the salivary 
and lacrimal glands of SS patients present abundant lymphocytic infiltration 
and atrophy (Nikolov & Illei, 2009). However, when B cell deficient SS-
prone non-obese diabetic (NOD) mice were transferred with IgG from SS 
patients, the saliva production were altered even in the absence of infiltrated 
lymphocytes in the salivary gland indicates the role of autoantibodies in the 




Robinson et al., 1998). Similarly, many SS patients with no glandular 
function retain substantial amounts of intact acinar tissues in their salivary 
glands. Furthermore, those acinar tissues regain functionality in -vitro 
(Dawson et al., 2001). Thus the etiology of SS is still unknown. But there are 
numerous underlying mechanisms suggested to contribute to this loss of 
secretory dysfunction, though no single mechanism has been identified as the 
primary cause. Lymphocytic infiltration, autoantibodies targeting muscarinic 
receptors, proinflammatory cytokines, nitric oxide, and apoptotic cell death 
of acinar cells all have been implicated as potential cause of secretory 
dysfunction of salivary gland (Kaleb et al., 2012). 
1.3.1. Lymphocytic infiltration  
Lymphocytic infiltration and epithelial cells activation mainly in salivary and 
lacrimal glands is the histopathological hall mark of SS (Chisholm & Mason, 
1968). The infiltrated lymphocytes in the salivary and lacrimal glands consist 
mainly of CD4
+
 T cells (initiation by Th1 and Th17 cells, progression by 
Th2 and Tfh cell) (Moriyama et al., 2014), B cells and lesser number of 
CD8
+
 T cells (Hamza et al., 2012). The balance between T and B cells 
depends upon the disease progression. According to the widely accepted 
American and European criteria and the more recently proposed criteria by 
American college of rheumatology minor salivary gland pathology is 




(focus score is the number of lymphocytic foci per 4mm
2
 surface in at least 
four informative lobules; a focus is define as a cluster of at least 50 
lymphocytes) (Vitali et al., 2002). T cells are recruited first to the site of 
infiltration followed by B cells. CD8
+
 T cells with increased expression of 
adhesion molecules and cell death surface receptor (Fas/FasL) molecules can 
directly kill the acinar cells in the salivary gland. Secretory dysfunction has 
long been considered as a result of glandular destruction mediated by 
lymphocytic infiltration in these tissues (Kaleb et al., 2012; Mavragani & 
Moutsopoulos, 2014; Voulgarelis & Tzioufas, 2010). 
1.3.2. Role of cytokines in salivary gland dysfunction 
Persistant inflammation can lead to chronic tissue damage and salivary gland 
dysfunction. Salivary glands from SS patients show increased expression of 
proinflammatory cytokines such as INFα and INF, TNFIL-6, IL-12, IL-
18 and BAFF, in contrast anti-inflammatory cytokines, such as IL-4 and 
transforming growth factor (TGFare undetectable or expressed at low 
level except for IL-10 (Roescher et al., 2009). Baturone et al. reported the 
significantly increased level of IL-1, IL-6, IL-10, TNF and IFN in serum 
of primary SS patients, and reported the  increased level  of IL-6 with poor 
quality of life (Baturone et al., 2009). IL-18 and its inducer IL-12 which 
plays an important role in Th1 driven autoimmune response are involved in 




development in the patient with primary SS (Bombardieri et al., 2004). 
IFNa major cytokines released from Th1 cells, regulates cell mediated 
immune responses through activation of natural killer cells, macrophages and 
CD8
+
 T cells (Cha et al., 2004). IFNor receptor knockout mouse models 
confirm the role of IFN in the loss of secretory function in SS. Ogawa et al. 
reported that IFN-stimulates the production of interferon gamma-induced 
protein 10 (IP-10) and monokine induced by gamma interferon (MIG) 
proteins from the SS ductal epithelium, and that IP-10 and MIG are involved 
in the recruitment of T cells into the salivary glands of SS patients (Ogawa et 
al. 2004; Ogawa et al. 2002).  
Cytokines released from Th2 cells can play an important role in SS: 
IL4 knockout NOD mice suggested that IL-4 affects saliva secretion via 
antibody production (anti-M3R autoantibody) and isotype switching (IgG1), 
IL-13 facilitates secretory dysfunction possibly through affecting mast cells 
in the salivary glands (Gao et al., 2006; Jin & Yu, 2013; Reksten et al., 2009). 
Not only Th1 and Th2 effectors cells but also Th17 cells which release the 
proinflammatory cytokines IL-17 have been studied for their role in SS 
pathogenesis (Reksten et al., 2009). Nguyen et al. reported that IL-17 is 
critical in inducing SS-phenotype in C57BL/6J mice (Nguyen et al., 2010), 
and reduction of IL-17A level by Ad5-IL17R:Fc blocking vector suppress 




Recently, Zhang et al. reportd that IL-17 derived from infiltrating 
lymphocytes impairs the integrity of tight junction through nuclear factor-kB 
(NF-kB) signaling pathway, and thus contribute to salivary gland 
dysfunction (Zhang et al., 2016). 
1.3.3. Role of B cell in salivary gland dysfunction 
Not only pathogenic T cells and cytokines but also loss of B cell tolerance is 
critical in development of autoimmune diseases including SS. BAFF can be 
detected in high levels in patients with autoimmune diseases as compared to 
HC (Varin et al., 2010). BAFF overexpression causes self-reactive B cell 
activation and B cell hyperactivity. BAFF in combination with IL-17  
influences the survival, proliferation, and differentiation of B cells in SLE 
(Cheema et al., 2001; Doreau et al., 2009). 
1.3.4. Role of autoantibodies in salivary gland dysfunction 
Traditionally salivary dysfuction was considered as the result of acinar tissue 
destruction after lymphocytic infiltration. However, more recently questions 
arised concerning SS patients who have substancial amounts of intact acinar 
tissues in their salivary glands but still suffer from xerostomia. These 
observation suggests the salivary gland functional disruption rather than 
acinar tissue destruction. In addition to salivary gland lymphocytic 
infiltration, SS patients exhibit hypergammaglobulinemia with a range of 




autoantibodies is the hall mark of the disease diagnosis detected in 60-70% 
of the patients (Hernandez-Molina et al., 2011). However, the levels of anti- 
Ro/SSA and anti-La/SSB autoantibodies are not associated with the disease 
activity. A number of other autoantibodies, such as anti-salivary gland 
protein-1, anti-carbonic anhydrase 6, anti-parotid secretory protein, anti-
muscarinic acetylcholine receptor 3 (M3R), anti-tissue kallikrein, and anti-α-
fodrin antibodies have been identified in SS (Bournia & Vlachoyiannopoulos, 
2012; Lee et al., 2013; Shen et al., 2012). Robinson et al. demostrated that 
transferring SS patients IgG to NOD.Igµ null mice results in salivary gland 
dysfuction (Robinson et al., 1998). NOD.Igµ null mice lack functional B 
lymphocytes and therefore lack the IgG autoantibodies. NOD.Igµ null mice 
do exhibit lymphocytic infiltration of the salivary and lacrimal galnds but fail 
to show secretory dysfuction. However transfering IgG from SS patients 
shows a 54% reduction in saliva production while transfer from HC has no 
effect (Robinson et al., 1998). Further the transfer of a monoclonal antibody 
against mouse M3R into NOD-scid mice presented a significant reduction in 
saliva secretion, while infusion of antibodies to Ro and La or parotid 
secretory protein had no effect on salivary gland secretory dysfunction. Anti-
M3R auto-antibodies have also been shown to affect the autonomic nervous 





1.4. Morphology of salivary gland and production of saliva 
Mammals possess three major (parotid, submandibular and sublingual) and 
numerous minor salivary glands scattered throughout the oral mucosa 
(Proctor, 2016). Salivary gland consists of multiple lobes; each lobule 
consists of a number of secretory units composed of acinar cells either serous 
or mucous, and ductal cells of several types as well as myoepithelial cells 
(Proctor, 2016). The acini form a blind end with a lumen surrounded by 
many secretory cells. The saliva produced in each acinus passes through 
intercalated, intra-lobular and excretory ducts before finally enters into main 
excretory duct. Saliva is a watery fluid containing electrolytes and a mixture 










 cotransporter, located at 
the basolateral membrane, use the Na
+
 gradient to elevate the intracellular 
Cl
−




transepithelial osmotic gradient driving water movement through the apical 
AQP5 channels and paracellular pathways. This leads to the secretion of 
isotonic plasma like primary fluid (Catalan et al., 2009; Delporte, 2009; 
Proctor & Carpenter, 2014). The final saliva composition depends on both 
the origin and the type of the salivary gland stimulated. Typically, salivary 
glands produce around 1 liter of saliva per day. Saliva has many functions, 
including protection and hydration of mucosal surface, initiation of digestion, 
protection from chemical and mechanical stress, and providing antimicrobial 
defense by production of antimicrobial substances (Delporte, 2013; Delporte 
& Steinfeld, 2006). Salivary dysfunction is clinically characterized by 
dysphagia, oral pain, dental caries, and infection from opportunistic 
microorganisms (Delporte et al., 2016). 
1.5. AQPs 
The AQPs are small hydrophobic approximately 270 amino acids integral 
membrane proteins which are widely expressed in animals and plants as well 
as in bacteria and archaea. AQPs exist as monomers of 28-30 kDa that can 
associate in tetramers (Delporte, 2009). AQPs structural analyses showed 
that each monomer consists of six transmembrane helices making three 
extracellular and two intracellular loops. The signature amino acid sequence 
motifs of the AQPs are two repeating Asn–Pro–Ala (NPA) sequences present 




date, at least 13 members of this channel family have been identified in 
mammals. Based on their permeability characteristics, the members of the 
AQPs family can be divided into two subgroups: AQP and aquaglyceroporin 
(Delporte, 2009). 
The AQP (AQP0, AQP1, AQP2, AQP4, AQP5, AQP6, and AQP8) 
are primarily water channel molecules, whereas the aquaglyceroporins 
(AQP3, AQP7, AQP9 and AQP10) are used for the transportation of glycerol 
and other small solutes. The transport function of many AQP can be 
inhibited by mercurial–sulfhydral-reactive compounds such as HgCl2 
(Delporte, 2009; Delporte & Steinfeld, 2006). 
 
AQPs contain six transmembrane helices three extracellular and two 
intracellular loops. The loops B and E, folding in the lipid bilayer, form a 




1.5.1. AQPs expression and role in saliva production 
The expression of mRNA level and detection of proteins of AQP1, AQP5 
and AQP3 has been confirmed by many researchers in human salivary 
glands including parotid, submandibular and sublingual, while the data for 
the presence of AQP4, AQP6 and AQP7 are still controversial and do not 
appear to play an important role in the production of saliva (Delporte, 2009). 
AQP5 seems to be the only AQP which plays a very clear functional role in 
the production of saliva. AQP5 is expressed at the apical membrane of acinar 
cells and intercalated ducts in the lacrimal and salivary glands (Takata et al., 
2004). AQP5-deficient mice secrete hypertonic saliva with substantially 
reduced volume (Ma et al., 1999), which is attributed to a decrease in the 
water permeability of salivary acinar cells (Krane et al., 2001). AQP1 also 
expressed in the salivary and lacrimal glands, which is confined to the 
capillary endothelial and myoepithelial cells. Transgenic mice lacking AQP1 
shows that AQP1 does not play a major role in saliva secretion (Delporte & 
Steinfeld, 2006). However, B cell depletion with rituximab increases both 
AQP1 expression in myoepithelial cells and saliva flow rate in patients with 
SS (Ring et al., 2006). Many researchers also investigated AQP1 and AQP5 
abnormal expression/distribution in salivary gland, and suggested its role in 





1.5.2 Potential role of AQPs in the pathogenesis of SS   
Major intrinsic proteins (MIP) are large superfamily of transmembrane 
proteins channels that are grouped together on the basis two highly 
conserved regions called NPA motif and several surrounding amino acids 
(Benga, 2012). The MIP superfamily includes three sub-families; AQPs, 
aquaglyceroporins and S-aquaporins (Benga, 2012). AQPs and 
aquaglyceroporins are fundamentally evolutionary conserved and are widely 
expressed in animals, plants as well as in bacteria and archaea (Kruse et al., 
2006). It has been shown that mouse antibodies raised against Escherichia 
coli (E. coli) AQPZ react with human AQP4 (Ren et al., 2012). BLAST 
(Basic Local Alignment Search Tool)-search of bacterial protein database 
using human AQP5 and AQP1 amino acid sequence as a query confirmed 
that AQP-Z, porin or aquaglyceroporins from many human oral bacteria 
showed a high degree of homology with human AQP5 and AQP1. B cell 
epitope analysis showed the presence of conserved linear epitope in the 
extracellular loop E which supports the notion that the loop E may be the 
target of cross-reacting autoantibodies produced against bacterial proteins.  
In this context, it was hypothesized that immune response to oral bacteria 
may produce cross-reacting autoantibodies against AQP5 and AQP1 via 
molecular mimicry and that anti-AQP1 and anti-AQP5 autoantibodies may 




1.6. Key research questions 
       This study will address the following key research questions: 
 Are there autoantibodies to AQP5 and AQP1 in the sera from SS 
patients? 
 Are there association between the presence/level of anti-AQP5/AQP1 
autoantibodies and the clinical parameters of SS patients? 
 Is SS associated with dysbiosis of oral microbiota? 
 Can oral bacteria invade into HSG cells and induce inflammation? 











2. Material and methods   
2.1. Human serum and saliva samples collection  
This study was done in compliance with the Helsinki declaration after 
approvals from the institutional review board of Seoul national university 
hospital (IRB number: 0912-011-302), the institutional review board of 
Seoul national university school of dentistry (IRB number: S-D20140022), 
and the institutional review board of Seoul St. Mary’s hospital (IRB number: 
KC13ONMI0646). For this study, serum samples were obtained from two 
groups of patients: 1) 10 primary SS patients enrolled at the rheumatology 
clinic, Seoul national university hospital who were diagnosed according to 
the 2002 American-European consensus group (AECG) classification criteria 
for primary SS (Vitali et al., 2002) and 2) 102 primary SS patients enrolled at 
the Korean initiative of primary SS (KISS) who fulfilled the 2002 American-
European consensus group (AECG) classification criteria and/or the 2012 
American college of rheumatology (ACR) criteria (Shiboski et al., 2012). All 
samples were obtained before starting treatment. In addition, resting and 
stimulated whole salivary flow rates were measured by spiting and 
masticatory stimuli using wax gum (GC America Inc, St. Alsip, IL, USA), 
respectively, according to the method previously described (Navazesh & 
Christensen, 1982). All patients were females with ages ranging from 21 to 




healthy female controls who did not show any signs of SS symptoms (mean 
age 37.1± 7.4 years). Subjects with systemic disease other than hypertension 
were excluded. Written informed consent was obtained from all the subjects.  
2.2. Total bacterial genomic DNA extraction 
Bacterial genomic DNA from oral bacteria was extracted using GeneJET 
genomic DNA purification kit (Thermo Scientific, Inc. Lithuania). Whole 
mouth wash pellet were first agitated with garnet beads 0.15 mm (MO BIO 
Laboratories, Carlsbad, CA, USA) for 10 min followed by incubation with 
gram-positive bacteria lysis buffer (20 mM Tris-Hcl, pH 8.0, 2 mM EDTA, 
1.2% Triton X-100, 20 mg/ml lysozyme before use) for 30 min. The rest of 
the steps for genomic DNA extraction were according to the manufacturer’s 
instruction. 
2.3. PCR amplification and pyrosequencing 
PCR amplification was performed using primers targeting from V1 to V3 
regions of the 16S rRNA gene with extracted DNA. For bacterial 
amplification, barcoded primers of 9F (5’-
CCTATCCCCTGTGTGCCTTGGCAGTC-TCAG-AC-
AGAGTTTGATCMTGGCTCAG-3’; underlining sequence indicates the 
target region primer) and 541R (5’-
CCATCTCATCCCTGCGTGTCTCCGAC-TCAG-X-AC-




subject) (http://oklbb.ezbiocloud.net/content/1001). The amplifications was 
carried out under the following conditions: initial denaturation at 95 °C for 5 
min, followed by 30 cycles of denaturation at 95 °C for 30 sec, primer 
annealing at 55 °C for 30 sec, and extension at 72 °C for 30 sec, with a final 
elongation at 72 °C for 5 min. The PCR product was confirmed by using 2% 
agarose gel electrophoresis and visualized under a Gel Doc system (BioRad, 
Hercules, CA, USA). The amplified products were purified with QIAquick 
PCR purification kit (Qiagen, Valencia, CA, USA). Equal concentrations of 
purified products were pooled together and removed short fragments (non-
target products) with Ampure beads kit (Agencourt Bioscience, MA, USA). 
The quality and product size were assessed on a Bioanalyzer 2100 (Agilent, 
Palo Alto, CA, USA) using a DNA 7500 chip. Mixed amplicons were 
conducted emlusion PCR, and then deposited on Pico titer plates. The 
sequencing was carried out at Chunlab (Chunlab Inc., Seoul, Korea), with 
GS Junior sequencing system (Roche, Branford, CT, USA) according to the 
manufacturer’s instructions.  
2.4. Pyrosequencing data analysis 
The basic analysis was conducted according to the previous descriptions in 
other studies (Chun et al., 2010; Hur et al., 2011; Kim et al., 2012). Obtained 
reads from the different samples were sorted by unique barcodes of each 




removed from the original sequencing reads. Any reads containing two or 
more ambiguous nucleotides, low quality score (average score < 25), or 
reads shorter than 300 bp, were discarded. Potential chimera sequences were 
detected by the bellerophone method, which is comparing the BLASTN 
search results between forward half and reverse half sequences (Huber et al., 
2004). After removing chimera sequences, the taxonomic classification of 
each read was assigned against the EzTaxon-e database (http://eztaxon-
e.ezbiocloud.net) (Kim et al., 2012), which contains 16S rRNA gene 
sequence of type strains that have valid published names and representative 
species level phylotypes of either cultured or uncultured entries in the 
GenBank database with complete hierarchical taxonomic classification from 
the phylum to the species. The richness and diversity of samples were 
determined by Chao1 estimation and Shannon diversity index at the 3% 
distance. Random subsampling was conducted to equalize read size of 
samples for comparing different read sizes among samples. The overall 
phylogenetic distance between communities was estimated using the Fast 
UniFrac (Hamady et al., 2010) and visualized using principal coordinate 
analysis (PCoA). To compare OTUs between samples, shared OTUs were 
obtained with the XOR analysis of CLcommunity program (Chunlab Inc., 




2.5. In silico analysis 
The human AQP5 and AQP1 amino acid sequence was BLAST-searched as 
query against bacterial proteins database. The sequences of the selected oral 
bacterial AQPs or porins were aligned with human AQP5 and AQP1 using 
BioEdit sequence alignment editor 
(http://www.mbio.ncsu.edu/bioedit/bioedit.html). The human AQP5/AQP1 
amino acid sequences were searched for linear B cell epitope using immune 
epitope database (http://tools.immuneepitope.org/bcell/). 
2.6. Cloning of human AQP5 and AQP1 and transfection of cells 
The human AQP5 cDNA was cloned into a pEGFP-N1 vector (Clontech, 
Mountain View, CA, USA) using XhoI and BamHI sites while both human 
AQP5 and AQP1 were cloned into a pcDNA3.1 vector (Invitrogen, Carlsbad, 
CA, USA) using BamHI and XhoI restriction sites. Cells were transfected 
with calcium phosphate precipitation method (Kingston et al., 2003). The 
following list of primers was used for amplification of DNA as shown in 
table 1. 
Tab. 1 List of primers used in AQP1 and AQP5 cloning  























2.7. Cell culture 
All cell lines were obtained from Korean cell line bank (KCBL, Seoul, 
Korea). CHO cells were cultured in F-12 medium containing 10% FBS and 
100 unit/ml penicillin and streptomycin, while HEK-293, MDCK and HSG 
were maintained in DMEM medium with 10% FBS and 100 unit/ml each 
penicillin and streptomycin. Transfected cells were maintained in the 
presence of G-418 (0.1-o.2 mg/ml). 
2.8. IIFA 
For IIFA, all tissues and cells were fixed with 4% paraformaldehyde in PBS 
pH 7.4, subjected to antigen retrieval by incubation in sodium citrate buffer 
(10 mM sodium citrate, 0.05% Tween-20, pH 6) at 105 °C for 20 min, before 
blocking and incubation with primary antibodies, which gave the best result 




The use of animals was approved by the Seoul national university animal 
care and use committee. After stimulating 12 week old C57BL/6 mice 
(Orient Bio Inc., Seongnam, Gyeonggi, Korea) with 5 μg/g body weight of 
pilocarpine (Sigma-Aldrich Korea, Seoul, Korea), the submandibular glands 
were removed and fixed with 4% paraformaldehyde in phosphate buffer 
saline (PBS) pH 7.4 overnight. The fixed tissues were immersed in 30% 
sucrose in PBS pH 7.4 and embedded in the optimal cutting temperature 
(OCT) compound. Cryostat sections were mounted on saline coated glass 
slides (Muto pure chemicals, Tokyo, Japan) and air dried. After antigen 
retrieval and permeabilization, the sections were blocked with 5% bovine 
serum albumin (BSA) in PBS and were then incubated with goat anti-AQP5 
antibodies (Santa Cruz, Paso Robles, CA, USA) and either the pooled SS or 
pooled control sera (1:200 dilution) overnight, followed by Alexa Fluor 488-
conjugated donkey anti-goat IgG (Invitrogen, Carlsbad, CA, USA) and CF
TM
 
594-conjugated rabbit anti-human IgG antibodies (Sigma Aldrich St Louis, 
MO, USA).  
CHO cells cultured on collagen coated glass slides were transfected with 
either pEGFP-N1-AQP5 or pEGFP-N1. MDCK cells were transfected with 
pcDNA3.1-AQP5 and subjected to selection with G418 (A. G. Scientific, 
San Diego, CA, USA). The transfected CHO cells were incubated with rabbit 




pooled control or the pooled SS sera (1:200 dilution), followed by Alexa 
Fluor 488-conjugated goat anti-rabbit and Alexa Fluor 555-conjugated goat 
anti-human IgG (Invitrogen, Carlsbad, CA, USA). The transfected MDCK 
cells were incubated with goat anti-AQP5 and various dilutions of either the 
control or SS sera, followed by Alexa Fluor 488-conjugated donkey anti-goat 
IgG (Invitrogen, Carlsbad, CA, USA) and CF
TM
 594-conjugated rabbit anti 
human IgG (Sigma Aldrich St Louis, MO, USA). To detect human IgA, 
Alexa flour 594-conjugated rabbit anti-human IgA antibodies (Jackson 
ImmunoResearch, West Grove, PA, USA) were used. All images were taken 
with a confocal microscope LSM 700 (Carl Zeiss, Jena, Germany). In the 
case of the stained MDCK-AQP5 cells, three areas of AQP5-expressing cells 
were randomly selected and sequentially imaged for the presence of anti-
AQP5 IgG/IgA. Because many SS samples had stained nuclei as well as 
AQP5, the relative intensities of the anti-AQP5 signals were determined by 
decreasing the brightness of the red signal until the signals of the anti-AQP5 
IgG/IgA disappeared. The mean of the ∆ brightness obtained in three images 
was used to express the level of anti-AQP5 IgG/IgA for each sample. The 
same method was followed for anti-AQP1 antibodies detection and analysis. 
2.9. Immunoprecipitation and western blot 
HEK-293 cells were transfected with pAQP5-EGFP or pEGFP-N1. Forty 




octyl--D-1-thioglucopyranoside, 50 mM Tris-HCl, and 150 mM NaCl, pH 
7.4). Proteins (250 µg of cell lysates) were incubated with 1 μg anti-AQP5 
antibodies, pooled control sera, or pooled SS sera overnight, followed by 
precipitation with protein A agarose beads (Pierce Biotechnology, Rockford, 
IL, USA). After washing, the beads were resuspended in Laemmli sample 
buffer containing -mercaptoethanol and incubated at 70 °C for 15 min. The 
proteins were separated on a 12% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), transferred to polyvinylidene difluoride 
(PVDF) membrane (Millipore, Billerica, MA, USA), and immunoblotted 
with goat anti-AQP5 or rabbit anti-GFP antibodies. 
2.10. Bacteria culture and staining 
Selected bacteria used in this study were from ATCC (American type culture 
collection) and KCOM (Korean collection for oral microbiology). Fn ATCC 
10953, Rothia mucilaginosa (Rm) KCTC19862, S. salivarius (Ss) KCTC 
5512, Eikenella corrodens (Ec) were grown in brain heart infusion (BHI) 
broth supplemented with hemin 5 µg/ml of hemin (Sigma, St Louis, MO, 
USA) plus 10 µg/ml of vitamin K under an anaerobic condition (5% H2, 10% 
CO2 and 85% N2), Ec were supplemented with 16% FBS. Pm KCTC 5323 
and P. histicola (Ph) KCTC 15171 were grown in KCTC-5457 medium and 
peptone yeast glucose broth respectively, under anaerobic condition as 




twice with PBS before doing any experiment. For the fluorescence studies, 
bacteria were stained with 5 μM of 5- (and 6-) carboxy-fluorescein diacetate 
succinimidyl ester (CFSE) (Molecular Probe, Carlsbad, CA, USA).  
2.11. Confocal microscopy of internalized bacteria  
HSG cells (2.5x10
4
) were seeded on a cover glass in a 24 well plate one day 
before infection. Overnight grown cells were infected with CFSE labelled Fn, 
Pm, Ph, Ss and Ec at MOI 1000 for 6 and 24 hours. Cells were rinsed with 
PBS and fixed with 4% paraformaldehyde in PBS for 15 min at room 
temperature. Excess aldehyde were quenched with 0.1 M glycine in PBS for 
5 min. Cells were then permeabilized with 0.3% Triton-X100 in PBS for 1 
min, followed by incubation with Rhodamine-phalloidin (dilution 1:150) 
((Invitrogen, Carlsbad, CA, USA) and Hoechst 33342 (1 µg/ml) for 15 min 
in PBS. In the final step cells were washed three times with distal water and 
mounted with mounting solution. 
2.12. Flow cytometric invasion assay  
Flow cytometric invasion assay was performed as previously described (Ji et 
al., 2010). Briefly, HSG cells were seeded (6 x10
4
) in 24-well plate in 
triplicate. For invasion assay, HSG cells were infected with CFSE-labeled 
bacteria at MOI 1000 for 6 and 24 hours at 37 °C. The cells were detached, 
washed and then analyzed by flow cytometry after quenching the 




blue. Non-infected live cells and cells fixed with 4% formaldehyde and 
exposed to the same amount of CFSE-labeled bacteria served as negative 
controls. The viability of the HSG cells were determined based on their 
forward scatter and the FL-3 fluorescence of the trypan blue staining, 
bacterial invasion was analyzed only for the live cells.  
2.13. Cytotoxicity test 
The cytotoxic effect of oral bacterial on HSG cells were determined by using 
a cell counting kit-8 (CCK-8) assay (Dojindo Laboratories, Kumamoo, 
Japan). HSG cells (18000 cells/well) were infected with oral bacteria Fn, Pm 
and Ss with multiplicity of infection (MOI) 50 and 100 for 6 and 24 hours. 
The cytotoxicity of HSG cells were measured by incubation with 10 µl of 
CCK-8 reagent per well for 90 min at 37 °C, optical density (OD) value was 
measured at 450 nm. The viability is based on the principle of conversion of 
a water-soluble tetrazolium salt, 2-(2-methoxy-4-nitrophenyl)-3-(4-
nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-
8), to a water-soluble formazan dye upon reduction by dehydrogenases in the 
presence of an electron carrier. HSG cells viability were expressed as a 




2.14. Real time reverse transcription polymerase chain reaction (RT-
PCR) 
Total RNA was extracted from HSG cells infected with Fn, Pm and Ss at 
MOI 50 and 100 for 6 and 24 hours or from mouse salivary glands infected 
with Fn and Pm using easy-BLUE
TM
 total RNA extraction kit (iNtRON 
Biotechnology, Inc. Korea). Complementary DNA (cDNA) was synthesized 
from 1µg of total RNA using oligo-dt and M-MLV reverse transcriptase 
enzymes (Promega corporation, Medison, USA) in a 25 µl reaction mix 
incubated at 40 °C for 10 min and 55 °C for 50 min. RT-PCR was performed 
using SYBR premix Ex Taq, ROX passive dye (Takara Bio, Otsu, Japan) in a 
20 µl reaction mixture containing 1 µl template cDNA. Amplification was 
performed in a fluorescence thermocycler (Applied biosystem 7500/7300 
real time PCR, Foster City, CA) under the following condition initial 
denaturation 95 °C for 2 min, followed by 40 cycles of denaturation at 95 °C 
for 15 sec, annealing 60 °C for 15 sec, elongation 72 °C for 40 sec. The 
specificity of the PCR product was verified by melting curve analysis and 
running on a gel. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 
mouse beta-actin gene was amplified in parallel with the gene of interest. 
Relative copy number compared to GAPDH was calculated using 2
-∆CT
. 
Each experiment was performed in triplicate. List of primers used in real 





Tab. 2 List of primers used in real time PCR 
Primer Gene ID 
Size 
(bp) 
Forward Primer Reverse Primer 
h-
GAPDH 





















































































http://www.ncbi.nlm.nih.gov/tools/primer-blast/,    https://mouseprimerdepot.nci.nih.gov/ 
 
2.15. Cytokines ELISA  
The RT-PCR data was further confirmed by measuring the amount of 
cytokines and chemokines released into the medium by HSG cells in 
response of Fn, Pm and Ss infection. The level of human IL-6 and IP-10 in the 
culture supernatant of HSG cells were measured using DuoSet® ELISA 
development systems (R & D Systems, Inc. Minneapolis, MN)) according to 




2.16 Peptide synthesis  
For epitope mapping synthetic peptides were synthesized in the form of 
linear or cyclic form corresponding to the three extracellular loops of AQP5 
(Peptron Inc. Daejeon, Korea). Amino acid sequences of peptides were 
selected after B cell epitope analysis. Peptides cover the three extra cellular 
loops of AQP5 including hemi-channel loop E, which make a pore for water 
transportation. Irrelevant peptides purchased from Sigma (Sigma-Aldrich 
Korea, Seoul, Korea) were also included in our study as listed in Table 3.  
Tab. 3 List of peptides used in epitope mapping 
AQP5 Loop A WPSALPT   (Linear) 
AQP5 Loop C CNNNTTQGC (C-C) 
AQP5 Loop C2 NNNTTQG (Linear) 
AQP5 Loop E1 GCSMNPARSFGC (C-C) 
AQP5 Loop E2 CMNPARSFGC (C-C) 
IR-Peptides (SCP0156) Sigma GRADSP 
 
2.17. Animal model 
The experimental protocol and animal handling procedures were conducted 
in accordance with the recommendations in the guide from the institute of 
laboratory animal resources Seoul national university under the laboratory 




mice were purchased from Orient-Bio (Orient-Bio, Seongnam, Korea) and 
housed under specific pathogen-free conditions in the laboratory animal 
facility at the school of dentistry, Seoul national university. The mice (n=20) 
were given randomly divided into four groups: Sham, Fn-group, Pm-group 
and Fn-Pm-group. The Fn and Pm group were inoculated 2x10
9
 each bacteria 
per mice while the Fn-Pm group received 10
9
 each bacteria in co-infection.  
 
 
2.18. Histology  
Freshly isolated mice salivary gland tissues were fixed with 
immunohistochemistry (IHC) zinc fixative solution for 48 hours and 
imbedded in paraffin. Paraffin embedded salivary gland tissues were serial 
sectioned 5µm each and stained by hematoxylin and eosin (H & E) for 
histological examination. Cold spring harbor online protocols were used for 




2.19. Statistical analysis   
A receiver operating characteristic (ROC) analysis by a nonparametric 
method and the Mann-Whitney U test were used to compare the levels of 
anti-AQP5 autoantibodies between the control and SS groups. Associations 
between measures of salivary rate and the presence of anti-AQP5 
autoantibodies were examined using one-way analysis of variance. Because 
some groups did not pass the normality test, the difference was also analyzed 
by Mann-Whitney U test. All statistics were performed using SPSS (SPSS 
Inc., Chicago, USA). The difference between control and experimental group, 
two tailed non-paired student’s t-test was performed. Logistic regression 











3.1. Homology between human and oral bacterial AQPs suggest 
immunological cross-reaction 
Amino acid sequence of human AQP5 and AQP1 were aligned with AQPs/ 
porins from eight most abundant species of oral bacteria. AQP5 showed 33-
39% identity and 51-57% similarity while AQP1 showed a 35-42% identity 
and 52-56% similarity with AQPs/porins from selected oral bacteria (Fig. 1 
and 2). The homologous sequences were conserved mostly at the 
transmembrane alpha helixes and the water channel pore forming loops B 
and E. The extracellular loop E and intracellular loop B insert into the 
membrane from the opposite site to make a pore for the water transport. 
Moreover, bepipred linear epitope prediction analysis confirmed the 
presence of conserved B cell epitope on the extracellular loops including 
loop E (Tab. 4) which supported the notion that human AQP5 and AQP1 
could be the target of cross reacting autoantibodies produced against oral 
bacteria.  In this context, we focused on the role of AQP5 and AQP1 as the 







Fig. 1 Multi sequence alignment of human and oral bacterial AQPs/ 
porins. The numbers in parentheses indicate percentages of identical and 
conserved amino acids. Identical and conserved amino acids are highlighted 
with dark gray and light gray, respectively. The extracellular and cytosolic 
domains are boxed with solid and dotted lines, respectively. 
Oral bacterial proteins used in multi sequence alignment 
Bacteria Protein Accession number 
[Prevotella nanceiensis] aquaporin |WP_018363007.1| 
[Neisseria mucosa] porin |WP_036491391.1| 
[Neisseria subflava] porin |WP_039862497.1| 
[Streptococcus parasanguinis] porin |WP_031574039.1| 





|WP_008822014.1| [Prevotella histicola] 





Fig. 2 Multi sequence alignment of human and oral bacterial 
AQPs/porins. The numbers in parentheses indicate percentages of identical 
and conserved amino acids. Identical and conserved amino acids are 
highlighted with dark gray and light gray, respectively. The extracellular and 
cytosolic domains are boxed with solid and dotted lines, respectively. 
Oral bacterial proteins used in multi sequence alignment 
Bacteria Protein Accession number 
[Prevotella nanceiensis] aquaporin |WP_018363007.1| 
[Prevotella melaninogenica] porin |WP_036863760.1| 
[Streptococcus oralis] aquaporin |WP_000713413.1| 
[Neisseria subflava] porin |WP_039862497.1| 
[Neisseria mucosa] porin |WP_036491391.1| 
[Prevotella histicola] aquaporin |WP_008822014.1| 



































3.2. Serum IgG from SS patients colocalize with AQP5 in mouse salivary 
glands 
To investigate the presence of autoantibodies against AQP5 in the sera of SS 
patients, sections of mouse salivary glands were dual stained with the pooled 
sera of four patients and AQP5-specific goat IgG that targets the cytoplasmic 
tail of murine, rat, and human AQP5. The amino acid sequence of AQP5 is 
highly conserved between humans and mice with 91% identities and 96% 
homology. Expression of AQP5 was observed in both the luminal and 
basolateral membrane of the acinar cells, as previously reported (Larsen et 
al., 2011). While the pooled control sera barely stained the mouse salivary 
glands, the SS sera strongly stained the nuclei and plasma membranes of the 
acinar cells (Fig. 3A). The signals of SS IgG showed a high degree of 
colocalization with those of AQP5-specific goat IgG, which was confirmed 














Fig. 3 Serum IgG from SS patients colocalize with AQP5 in the mouse 
salivary glands. (A) Sections of the mouse submandibular gland were 
stained with goat anti-AQP5 antibodies and either the pooled control or 
pooled SS sera followed by Alexa Fluor 488-conjugated anti-goat IgG and 
CFTM 594-conjugated anti-human IgG. The areas of mucous and serous 
acini were imaged with confocal microscopy. D: duct; arrows: nuclei. (B) 
The colocalization of green and red signals in five images was calculated 











3.3. Serum IgG from SS patients selectively stain AQP5-GFP-
transfected cells 
Because SS patients may have autoantibodies against other proteins 
expressed in the salivary gland, the specificity of the autoantibodies was 
further investigated with CHO cells transfected with a transgene encoding 
GFP alone or a human AQP5-GFP fusion protein. While the GFP was 
dispersed throughout the cytoplasm and nuclei, AQP5-GFP was localized 
mostly to the plasma membranes and vesicular organelles. The anti-AQP5 
goat IgG stained the CHO cells expressing AQP5-GFP but not those 
expressing GFP alone. The pooled SS sera stained the nuclei of the CHO 
cells regardless of the type of transgene but also specifically stained the cells 
expressing AQP5-GFP. The pooled control sera did not stain either GFP- or 
AQP5-GFP-expressing cells (Fig. 4A). The signals of both anti-AQP5 goat 
IgG and SS IgG overlapped with the signal of GFP localized to the plasma 
membrane and intracellular vesicles in the AQP5-GFP-expressing cells, 











Fig. 4 Serum IgG from SS patients selectively stained AQP5-GFP-
transfected cells. (A) CHO cells were transfected with either pEGFP-N1 or 
pAQP5-EGFP. The transfected cells were stained with goat anti-AQP5 
antibodies, control sera, or SS sera (red) together with anti-GFP antibodies 
(green). (B) The colocalization of green and red signals in 18 images was 













3.4. Both the control and SS sera immunoprecipitate AQP5-GFP  
The selective staining of AQP5-GFP but not of GFP by the SS sera suggests 
that AQP5 acts as an autoantigen in the SS patients. However, colocalization, 
i.e., co-occurrence of two fluorophores in the same pixel, does not 
necessarily mean that the two signals target the same molecule. Therefore, 
the specific binding of SS IgG to AQP5 was further studied by 
immunoprecipitation. HEK-293 cells were transfected with either pEGFP-N1 
or pAQP5-GFP which express the 27 KD GFP and 55 KD AQP5-GFP 
proteins, respectively (Fig. 5A). The anti-AQP5 IgG precipitated the AQP5-
GFP, which was not precipitated from the lysates of the HEK-293 cells 
expressing GFP alone. Both the control and SS sera precipitated the AQP5-
GFP, suggesting the presence of autoantibodies against AQP5 not only in the 
SS sera but also in the control sera (Fig. 5B left panel). When decreased 
amounts of sera were used, however, only the SS sera precipitated AQP5-
GFP (Fig. 5B right panel). In an additional blinded experiment using several 









Fig. 5 Both control and SS sera immunoprecipitated AQP5-GFP. HEK-
293 cells were transfected with either pEGFP-N1 or pAQP5-EGFP. (A) 
Lysates of non-transfected and transfected HEK-293 cells were separated by 
SDS-PAGE and immunoblotted with anti-AQP5 or anti-GFP antibodies. (B) 
Lysates of HEK-293 cells transfected with either pEGFP-N1 or pAQP5-
EGFP were incubated with anti-AQP5 antibodies, control sera, or SS sera. 
The immune complexes precipitated with protein-A agarose beads were 













Fig. 6 Immunoprecipitation of AQP5-GFP with blinded sera samples. 
Lysates of HEK-293 cells transfected with pAQP5-EGFP were incubated 
with anti-AQP5 antibodies, and blinded sera from HC and SS patients. The 
immune complexes precipitated with protein-A agarose beads were 












3.5. Higher levels of anti-AQP5 IgG and IgA were detected in the SS 
sera by IIFA 
Currently, the standard method to detect anti-AQP4 antibodies for the 
diagnosis of neuromyelitis optica is with IIFA (Jarius et al., 2010). Therefore, 
a similar cell-based IIFA was developed by over-expressing AQP5 in 
MDCK an epithelial cell which have been widely used in studies on AQP5 
function (Kosugi-Tanaka et al., 2006; Wellner et al., 2005). The staining 
protocol was first optimized with the pooled sera. Both the SS and control 
sera contained anti-AQP5 IgG; however, a clear difference in their titers was 
observed (Fig. 7A). The 1:200 dilution was chosen to screen 53 control and 
112 SS samples for anti-AQP5 IgG. The anti-AQP5 IgG was detected in 43 
control and 103 SS samples with a significant difference in their intensities 
(p < 0.0001). When the cut-off value was set as the mean+2 SD of the 
control values, 35 (31.3%) SS samples were positive for the anti-AQP5 IgG 
(Fig. 7B left panel, cut-off 1). When the cut-off value at which the accuracy 
was the highest was chosen from the ROC curve (Fig. 7B right panel), 17 
(32.1%) control and 82 (73.2%) SS samples were positive for the anti-AQP5 
IgG, resulting in a sensitivity of 0.73 and a specificity of 0.68 (Fig. 7B left 
panel, cut-off 2). SS sera samples were also screened for the presence of 
anti-AQP5 IgA with a 1:20 dilution (Fig. 7C). The anti-AQP5 IgA was 
detected in only one (1.9%) control and 15 (13.4%) SS samples, where the 






Fig. 7 Higher levels of anti-AQP5 IgG and IgA were detected in the SS 
sera by IIFA. (A) MDCK cells over-expressing AQP5 were stained with 
anti-AQP5 antibodies and various dilutions of either the control or SS sera, 






594-conjugated anti-human IgG (red). (B) The intensities of the red signals 
for anti-AQP5 IgG were expressed by the magnitude of brightness that was 
reduced until the staining of AQP5 disappeared. A ROC curve for the levels 
of anti-AQP5 IgG is shown. The arrow indicates the value used for cut-off 2 
in the left panel. (C) MDCK cells over-expressing AQP5 were stained with 
anti-AQP5 antibodies and either the control or SS sera (1:20 dilution), 
followed by Alexa Fluor 488-conjugated anti-goat IgG (green) and Alexa 
Fluor 555-conjugated anti-human IgA (red). (D) The intensities of the red 
signals for anti-AQP5 IgA were expressed by the magnitude of brightness 















3.6. Anti-AQP1 IgG and IgA were detected in the sera of patients  
with SS 
To detect anti-AQP1 autoantibodies in SS patients sera, MDCK cells 
overexpressing full-length human AQP1 were double stained with anti-
AQP1 antibodies and sera from either control subjects (n=52) or SS patients 
(n=112). By screening sera diluted to 1:200 for the presence of anti-AQP1 
IgG, autoantibodies were detected in 23 patients with SS (20.5%), and the 
sera with anti-AQP1 IgG showed a high degree of colocalization between the 
signals of human IgG and those of AQP1-specific rabbit IgG. None of the 
control sera was positive for anti-AQP1 IgG (Figure 8A and B). Among the 
anti-AQP1 IgG-positive SS sera, 19 samples were also positive for anti-
AQP5 IgG, in the other four samples the anti-AQP5 IgG was also detected 
but at lower levels than the cut off used for positivity. By screening sera 
diluted to 1:20 for the presence of anti-AQP1 IgA, autoantibodies were 
detected in eight SS samples (7.1%) but in none of the control sera (Figure 
8C and D). Seven of the anti-AQP1 IgA-positive sera were also positive for 
anti-AQP5 IgG and IgA, and another sample was positive for anti-AQP5 IgG. 
However, none of the samples with anti-AQP1 IgA were positive for anti-
AQP1 IgG. Altogether, anti-AQP1 autoantibodies were detected in 27.2% of 




those of the corresponding anti-AQP5 IgG/IgA, a significant positive 
















Fig. 8 Detection of anti-AQP1 IgG and IgA in the sera of SS patients 
(A) MDCK cells over-expressing AQP1 were stained with anti-AQP1 
antibodies and either control or SS sera (1:200 dilution), followed by Alexa 
Fluor 488-conjugated anti-rabbit IgG (green) and Alexa Flour 555-
conjugated anti-human IgG (red). The colocalization of green and red signals 
in the three images was calculated using Mander’s coefficient. *, p = 0.0001 
(B) The intensities of the red signals for anti-AQP1 IgG were expressed by 
the magnitude of brightness that was reduced until the AQP1 staining 
disappeared. (C) MDCK cells over-expressing AQP1 were stained with anti-
AQP1 antibodies and either control or SS sera (1:20 dilution), followed by 
Alexa Fluor 488-conjugated anti-rabbit IgG (green) and Alexa Fluor 555-
conjugated anti-human IgA (red). The colocalization of green and red signals 
in the three images was calculated using Mander’s coefficient. *, p = 0.02 (D) 




magnitude of brightness that was reduced until the AQP1 staining 
disappeared. (E) The intensities of anti-AQP1 IgG or IgA and of anti-AQP5 




















3.7 Homology between human AQP1 and AQP5 suggest immunological 
cross-reactivity 
AQP1 is relatively closely related to AQP5 in the phylogenic tree of 13 
human AQPs, AQP1 has  44% identity and 62% similarity with the amino 
acid sequence of human AQP5 (Fig. 9A). In contrast to anti-AQP5 
autoantibodies, for which the presence of anti-AQP5 IgA had overlapped 
with the presence of anti-AQP5 IgG, the presence of anti-AQP1 IgA 
coincided with the presence of anti-AQP5 IgA, rather than the presence of 
anti-AQP1 IgG. Similarly, the presence of anti-AQP1 IgG overlapped with 
the presence of anti-AQP5 IgG. Therefore, anti-AQP1 autoantibodies are 
likely to be a byproduct of an antibody response to AQP5. A significant 
positive correlation between the intensities of the two autoantibodies 
supports it (Fig. 8E). In contrast to AQP5 in which the full lengths of loops B 
and E are exposed to the cytosolic and extracellular compartments 
respectively, the middle portion of loops B and E in AQP1 is embedded 
within the membrane. However, short stretches of conserved sequences were 
observed in loop B, loop D, and loop E, as well as the C-terminal 





Fig. 9A. The evolutionary relationship of human AQPs. A phylogenic 









Fig. 9B. Sequence alignment of human AQP5 and AQP1. Identical and 
conserved amino acids are highlighted with dark gray and light gray, 
respectively. The extracellular and cytosolic domains are boxed with solid 











3.8. The presence of anti-AQP5 autoantibodies was associated with low 
resting salivary flow rate  
Associations between the presence of autoantibodies to AQP5 and AQP1 and 
salivary flow rates were examined in patients for whom the salivary flow 
rates were recorded at the time of sampling. The presence of anti-AQP5 IgG 
was associated with low resting salivary flow but not with stimulated 
salivary flow. The patients with anti-AQP5 IgA presented lower levels of 
both resting and stimulated salivary flow than those without the 
autoantibodies. However, significance was achieved for only resting salivary 
flow. In contrast, the presence of neither anti-AQP1 IgG nor IgA had a 
significant effect on salivary flow. Because more than one-half of the SS 
patients who negative for anti-AQP1 autoantibodies had anti-AQP5 
autoantibodies that were associated with a low resting salivary flow, the 
effect of anti-AQP1 autoantibodies on salivary flow was also examined in 
patients with anti-AQP5 autoantibodies. However, no difference in either 
resting or stimulatory salivary flow was observed by the additional presence 
of anti-AQP1 autoantibodies. Importantly, the presence of either anti-Ro or 
anti-La antibodies which was the hall mark of disease diagnosis was not 






Tab. 5 Association between presence of autoantibodies and salivary flow 
rates 







Resting salivary flow 
0.096 (0.044, 0.148) 













Stimulated salivary flow 
0.554 (0.362, 0.747) 













Resting salivary flow 
0.070 (0.046, 0.093) 













Stimulated salivary flow 
0.556 (.444, 0.667) 













Resting salivary flow 
0.068 (0.041, 0.094) 














Stimulated salivary flow 
0.518 (0.403, 0.633) 













Resting salivary flow 
0.064 (0.042, 0.087) 













Stimulated salivary flow 
0.534 (0.430, 0.638) 














Resting salivary flow 
0.050 (0.025, 0.074) 













Stimulated salivary flow 
0.517 (0.374, 0.660) 









Resting salivary flow 
0.040 (0.002, 0.149) 













Stimulated salivary flow 
0.482 (0.238, 0.726) 











Resting salivary flow 















Stimulated salivary flow 
0.550 (0.407, 0.692) 







 a: ANOVA 






















3.9. Epitope mapping of anti-AQP5 autoantibodies in the sera of 
patients with SS  
Autoantibodies to AQP5 were associated with decreased resting salivary 
flow rate. Immune recognition of autoantigen is essential for development of 
Ag-specific immunotherapy. To identify the epitope of AQP5 present on the 
cell surface, five peptides corresponding to the three extracellular loops of 
AQP5 were designed after searching for linear-B cell epitope using immune 
epitope database (Fig. 10A). Based on anti-AQP5 autoantibodies screening 
results (Fig. 7B), 12 SS and 1 control sera were selected above cut-off 1 and 
12 SS and 12 control sera above cut-off 2 for epitope mapping experiment. 
Purified IgG from SS and HC were also included in this experiment, 
individual serum samples were pre-incubated with synthetic peptides 
overnight and then stained MDCK-AQP5 expressing cells, human IgG were 
detected by IIFA. 76% of the sera from SS reacted with at least one peptide 
as compared to 21% of the control sera. IgG from 18 SS patients (72%) 
recognized either linear or cyclic peptides to loop-C, while IgG from 16 SS 
patients (64%) recognized any of the two cyclic peptide to loop-E, 44% of 
the sera showed reactivity with the linear peptides corresponding to loop-A 
(Tab. 6). Interestingly IgG from 6 SS patients (24%) recognized none of the 
synthetic peptides; the final data were presented as mean of all sera samples 
(Fig. 10B). Pre-incubation of purified IgG with synthetic peptides 




overexpressing MDCK cells (Fig. 10C). No significant reactivity was found 


























 Tab. 6 Epitope mapping of anti-AQP5 autoantibodies in the sera of 
patients with SS 
  Blocking Peptides 
Sample ID Cont. A C C2 E1 E2 IRP 
005-034 (Cau-P22) 12.8 10.1 11 9.2 5.8 12.1 14 
005-043 (Cau-P29) 6.3 10.6 6.3 1.2 5.8 7.3 12.5 
005-046 (Cau-P30) 15 5 4.3 6.2 9.5 10.7 15 
005-060 (Cau-P42) 10.3 7.8 7.6 5.7 5.6 16.6 9.8 
005-063 (Cau-P44) 13.7 6.8 12.1 3.8 6.8 5.7 10.7 
005-072 (Cau-P51) 14.9 9.0 10. 7.0 7.8 6.9 11.9 
005-073 (Cau-P52) 10.2 7.8 5.8 7.6 9.8 6.7 11.2 
005-076 (Cau-P54) 7.4 7.5 8.2 7.5 6.7 5.9 5.4 
005-103 (Cau-P73) 16.7 9.9 10.9 12.5 9.6 12.6 13.8 
005-105 (Cau-P75) 15.1 9.25 9.1 8.7 4.1 6.7 15.5 
005-128 (Cau-P92) 18.1 14.9 16.0 15.2 16.7 15.9 16.9 
005-141 (Cau-P101) 10.6 8.1 7.7 3.1 6.2 12 8.1 
005-018 (Cau-P6) 15.1 8.1 10.1 9.9 10.6 6.0 15.3 
005-020 (Cau-P8) 0.5 5 3.8 2.3 2.2 1.7 7.5 
005-021 (Cau-P9) 5 6.1 5.7 3.1 3.7 3.8 7 
005-024 (Cau-P12) 3.6 3.6 6.3 7.2 4.2 5 6.5 
005-025 (Cau-P13) 4.5 3.6 1.2 6.7 6.2 2.6 3.7 
005-029 (Cau-P17) 8.6 5.2 4.3 4.3 3.2 2.8 7 
005-031 (Cau-P19) 6.3 5.2 2.7 1.5 2.8 2.2 6.3 
005-032 (Cau-P20) 11.1 6.3 4.1 6 3.3 6.8 7.8 
005-035 (Cau-P23) 12.6 8.5 8.7 6.8 12.2 10.7 11 
005-036 (Cau-P24) 16.2 9 12.3 8.5 6.6 9 11.6 
005-039 (Cau-P26) 1.1 5 3.8 4.2 2.1 2.3 2.8 
005-041 (Cau-P28) 10.9 12.6 9.8 8.8 9.7 9.2 12.7 
SS-purified IgG 21.2 11.1 15.1 12.4 4.5 10.3 19.5 
(Cau-C3) 7.1 9.7 7.2 17.3 11.1 9.3 9 
(Cau-C4) 8.2 11.3 7.3 6 8 9.2 10 
(Cau-C9) 5.3 9.2 10.1 10.3 9 9.5 9.3 
(Cau-C11) 5.3 6.8 8.3 8.7 9.8 5.6 6.3 
(Cau-C13) 7.8 11.5 8.0 10.2 6.5 7.7 7.9 
(Cau-C19) 9.2 9.3 7.7 12.5 9.1 12 10.3 
(Cau-C20) 11.5 10.0 14.1 7.11 9.1 10.2 10.5 
(Cau-C26) 7.5 8.6 12.8 12.5 9.3 8.5 6.6 
(Cau-C35) 5 6.1 6.2 6.8 4.3 2.3 6.3 
(SNUH-C2) 10.5 11.9 12.2 9.6 10.3 12.5 7.7 
(SNUH-C4) 5.3 4.2 5 9 6.5 7.1 7 




(SNUH-C3) 7.5 2.5 5.3 8 8.6 8.3 7.3 
Sigma-Cont. IgG 19.6 24.6 19.4 20.8 20.5 16 17.4 
Anti-AQP5 autoantibodies inhibition by synthetic peptides 
       
20% 30% 40% 50% 60% 70% 80% 
                                    
 
 
Fig. 10 Synthetic peptides blocked the binding of anti-AQP5 IgG in the 
sera from SS patients. (A) Synthetic peptides covering the extracellular 




individual serum samples were pre-incubated with synthetic peptides 
overnight and then stained MDCK-AQP5 expressing cells, the intensities of 
the red signals for anti-AQP5 IgG were expressed by the magnitude of 
brightness that was reduced until the staining of AQP5 disappeared the data 















3.10. Change in oral microbiota was associated with dryness of mouth 
Growing evidence suggests that dysbiosis of microbiota is associated with 
the pathogenesis of several diseases (Carding et al., 2015; Jiang et al., 2015; 
Li et al., 2014; Ray & Dittel, 2015; Scher et al., 2015; Vujkovic-Cvijin et al., 
2013). Therefor a total 50 samples were analyzed for microbiota 
communities from HC (n=15), SC (n=10) and SS patients (n=25). From 50 
samples a total 473869 valid reads were obtained with average 9477 read per 
sample resulted in 99.15% good’s coverage per sample. First the overall 
bacterial communities of HC, SC and SS were compared using UniFrac, a 
phylogeny-based distance metric ranging from 0 (complete identical) to 1 
(completely different). PCoA clustering reveals clear separation between 
communities from HC and dry mouth (both SC and SS). Although, there was 
no separation between SC and SS, SC made a sub-cluster inside SS bacterial 
communities (Fig. 11A). Further, the intragroup UniFrac distance of HC 
(0.0546+ 0.0276) was higher than SS (0.0405+ 0.0184) and SC (0.0384+ 
0.0234), suggested increased inter-subject variability in HC, followed by SS 
and SC respectively (Fig. 11B). In addition, the intergroup UniFrac distance 
of HC (0.0546+ 0.0276) was significantly smaller than intragroup distance 
with SC (0.067+ 0.024) and SS (0.068+ 0.024)  (Fig. 11C) suggesting a 
significant difference in the oral microbiota of HC and microbiota associated 




observed between intra-UniFrac distance of SC (0.0384+ 0.0234) and inter-
UniFrac distance with SS (0.0457+ 0.0160) suggesting a relatively similar 










Fig. 11 Microbial biodiversity decreased in dry mouth condition. A) 
Principal coordinate analysis (PCoA) plot based on weighted UniFrac value 
showing the similarity among the HC (n=15), SC (n=10) and SS (n=25) 
patients. B) Variation in bacterial communities’ composition with in the 
same HC group and those between SC and SS patients. C &D, The species 






Then, alpha diversity was compared between HC, SC and SS groups. The 
species richness of HC microbiota estimated by Chao1 (425.51 + 80.96) was 
not significantly different from SC (385.91 + 67.87) and SS (426.59 + 83.71) 
(Fig. 12A). Interestingly, the diversities of microbiota determine by Shannon 
index was significantly changed in SS (4.54 + 0.44) as compared to the 
diversity in HC (4.28 + 0.34) and SC (4.19 + 0.42) (Fig. 12B). 
 
 










Next, the relative abundance of each taxon among different groups was 
compared. Although a total 20 different phyla were detected from the saliva 
samples, Firmicutes, Proteobacteria Actinobacteria, Bacteroidetes and 
Fusobacteria encompass the majority of the sequences (>95% in HC and >99% 
in SC and SS group). The relative abundance of major phyla observed in HC 
was significantly different from that of SC and SS patients (Fig. 13). In 
comparison to the HC, phylum Firmicutes and Actinobacteria were 
significantly increased while Proteobacteria and Fusobacteria were 
significantly decreased in both SC and SS group respectively. The 










Fig. 13 Relative abundance of major phylum and genus between HC and 
dry mouth condition. Bacterial DNA extracted from mouth wash samples 
obtained from HC (n=15), SC (n=10) and primary SS (n=25) were analyzed 
by pyrosequencing of amplified 16S rRNA fragments. Double pie charts 










At the genus level, Streptococcus which constituted up to 38.96 percent of 
the microbiota from the HC group was increased in both SC (68.56%) and 
SS group (67.48%), other major genera e.g. Neisseria,  Haemophilus, 
Veillonella, Fusobacterium decreases both in SC and SS groups while 
Prevotella selectively increased in SS. Other genera also showed a difference 
in the relative abundance (Table 7). At the species level, the abundance of 
most of the bacterial species e.g. Haemophilus parainfluenzae, Neisseria 
subflava, Neisseria perflava, Veillonella dispar was significantly decreased 
in dry mouth condition. Among the bacterial species only the abundance of 
Prevotella histicola was selectively increased in SS patients (Table 8). 
The change in abundance of oral bacterial species and association with SS 
risk was determined by logistic regression analysis using a forward method, 
Prevotella melaninogenica was found associated with increased SS risk (OR 











Tab. 7 Relative abundance of major phylum and genus in HC and dry 
mouth condition 
  
HC (n=15) SC (n=10) SS (n=25) P=Value 
Phylum Firmicutes 52.16 (71.94) 72.85 (55.13) 77.82 (58.96) 0.0006 
 
Proteobacteria 31.97 (61.05) 9.84 (52.29) 4.36 (47.15) 0.0001 
 
Actinobacteria 3.18 (9.00) 9.02 (18.36) 5.38 (17.96) 0.0082 
 
Bacteroidetes 4.62 (15.03) 1.76 (16.47) 4.72 (20.07) 0.1672 
 
Fusobacteria 2.33 (23.63) 1.15 (2.03) 0.58 (4.71) 0.0032 
Genus Streptococcus 38.96 (82.49) 68.56 (50.00) 67.48 (54.02) 0.0004 
 
Neisseria 20.24 (45.95) 7.73 (51.09) 0.51 (35.23) 0.0003 
 
Haemophilus 8.74 (33.47) 1.06 (5.72) 1.70 (13.81) 0.0004 
 
Veillonella 5.15 (21.49) 1.01 (16.12) 3.24 (15.09) 0.0681 
 
Prevotella 2.29 (13.47) 1.22 (16.05) 3.89 (19.76) 0.0909 
 
Rothia 1.11 (5.94) 4.69 (18.07) 2.59 (14.94) 0.0024 
 
Actinomyces 1.37 (7.98) 1.63 (6.90) 2.01 (8.46) 0.8796 
 
Fusobacterium 1.64 (22.79) 0.85 (1.67) 0.55 (4.20) 0.0131 
 
Granulicatella 1.08 (2.89) 2.38 (4.53) 1.33 (6.11) 0.1540 
 
Gemella 0.47 (3.41) 0.51 (4.77) 0.47 (13.80) 0.9650 
 
Porphyromonas 0.35 (4.09) 0.21 (1.62) 0.05 (2.31) 0.0449 
 
Leptotrichia 0.51 (3.62) 0.18 (1.38) 0.07 (1.28) 0.0015 
 
Lautropia 0.18 (6.45) 0.01 (0.51) 0 (0.24) 0.0000 
 
Lactobacillus 0 (0.34) 0 (0.02) 0.01 (3.59) 0.0380 
 
Parvimonas 0.03 (0.60) 0.02 (1.02) 0.02 (5.11) 0.9613 
 
Campylobacter 0.29 (2.76) 0.04 (0.21) 0.01 (0.24) 0.0000 
 
Oribacterium 0.18 (1.84) 0.04 (0.85) 0.04 (0.46) 0.0194 
 
Capnocytophaga 0.19 (2.10) 0.06 (0.51) 0.02 (0.25) 0.0005 
 
Corynebacterium 0.13 (1.74) 0.03 (0.60) 0.03 (0.65) 0.0289 
 





























0.00 0.00 0.00 0.97 






0.00 0.02 0.00 0.21 















0.00 0.06 0.00 0.26 






0.01 0.27 0.00 0.17 






0.03 0.02 0.02 0.88 















0.00 0.00 0.00 0.58 






0.00 0.00 0.03 0.02 






0.03 0.82 0.02 0.06 






0.00 0.02 0.00 0.27 






0.00 0.00 0.00 0.15 






0.00 0.00 0.00 0.18 















0.00 0.00 0.02 0.07 






0.00 0.00 0.00 0.44 






0.02 0.00 0.25 0.04 






0.02 0.07 0.00 0.85 















0.00 0.03 0.00 0.70 













0.00 0.19 0.00 0.01 






0.03 0.20 0.01 0.31 






0.01 0.16 0.00 0.24 
























0.01 0.09 0.00 0.49 















0.02 0.10 0.01 0.97 






0.00 0.65 0.00 0.03 






0.00 0.01 0.00 0.14 






0.03 0.07 0.01 0.73 






0.00 0.04 0.00 0.79 






0.00 0.54 0.00 0.02 






0.00 0.01 0.00 0.77 






0.01 0.03 0.00 0.91 















0.04 0.73 0.10 0.01 






0.04 0.50 0.07 0.03 






0.01 0.33 0.05 0.01 






0.02 0.41 0.00 0.15 
























0.01 0.03 0.01 0.79 






0.01 0.72 0.00 0.03 




(0.07) (0.19) (7.14) 






0.04 0.07 0.01 0.33 






0.04 0.73 0.06 0.05 















0.03 0.08 0.17 0.01 






0.00 1.00 0.01 0.03 






0.02 0.18 0.01 0.46 






0.00 0.04 0.00 0.11 






0.04 0.41 0.08 0.04 






0.04 0.17 0.01 0.79 






0.02 0.08 0.01 0.90 















0.00 0.20 0.00 0.02 






0.02 0.04 0.03 0.36 






0.04 0.11 0.02 0.91 















0.01 0.81 0.01 0.05 






0.04 0.18 0.01 0.52 






0.02 0.28 0.00 0.11 















0.02 0.14 0.02 1.00 






0.01 0.07 1.00 0.02 
        










3.11. Bacteria relative abundance was not associated with high serum 
antibodies level  
To investigate the hypothesis of relative abundance and serum antibodies 
level to oral bacteria.  Ss, Rm, Ph, and Pm oral bacteria were selected based 
on possessing identical or homologous AQPs/porins to human AQP5/1. The 
antibodies produced against these bacteria may cross react with human 
AQP5/1. Based on pyrosequencing data, Rm is sicca associated while Ph 
was significantly increased in SS. Relative abundance of Ss and Pm was not 
significantly different among the three different groups (Fig. 14A, left panel). 
Serum samples from SS (n=111) and HC group (n=53) were screened for the 
presence of antibodies to  selected oral bacteria whole cell lysate using 
ELISA, for data analysis each group was sub-divided into anti-AQP5/1 
positive and anti-AQP5/1 negative group (Fig. 14B, right panel). No 
significant difference was found in serum antibodies level between HC and 
SS patient to selected oral bacteria except for Rm where the anti-Rm serum 
antibodies titer was significantly decreased in SS. No association was found 
between the presence of auto-antibodies to AQP5/1 and high titer of serum 










Fig. 14 Oral bacteria relative abundance and serum antibodies level. (A) 




including Ss, Rm, Ph and Pm was determined between HC, SC and SS. (B) 
Serum antibodies level to whole bacterial cell lysate was determined by 























3.12. Selected oral bacteria invade in-vitro into the HSG cells 
Bacterial invasion has been suggested as the potential primary step to initiate 
the disease process. To determine the role of oral bacteria in the pathogenesis 
of SS; Ph a significantly increased bacteria in SS (Tab. 8) and Pm which was 
associated with increased SS risk were selected to test for their invasiveness 
to HSG cells. Moreover, Ec and Ss was also included, the former bacteria is 
negatively associated with SS risk while the latter is the major commensal 
bacterial specie increased in sicca symptoms. Fn was also chosen because of 
its high invasive ability among the several oral species with known invasive 
capabilities. HSG cells were co-cultured with CFSE-labelled bacteria for 6 
and 24 hours and the invasion was determined by both flow cytometry, to 
quantify the internalized bacteria into HSG cells, the fluorescence intensity 
of adhered CFSE-labeled bacteria to the cell surface was quenched by trypan 
blue treatment, and the internalized bacteria was quantified by measuring the 
mean florescence intensity (MFI) using flow cytometry as shown (Fig. 15A). 
Fn are highly invasive into HSG cells followed by Pm, Ph, Ec and Ss 
respectively. Prolong incubation up to 24 hours further increased the bacteria 
invasion into HSG cells. The total numbers of different bacteria’s 
internalized to HSG cells were compared with that of Fn (Fig. 15B). In 




laser scanning microscopy. CFSE labelled bacteria were found inside the cell 




 Fig. 15 Assessment of oral bacteria invasion into HSG cells by confocal 
microscopy and flow cytometry. A) HSG cells were co-cultured with 
CFSE-labelled bacteria at MOI 100 for 6 and 24 hours and analyzed by flow 




negative control and fixed cells infected with bacteria. B) Adjusted MFI for 
the total numbers of different bacteria’s internalized to HSG cells were 
compared with that of Fn. C) HSG cells (1x10
5
 cells/well) were seeded onto 
cover slide in a 24-well plate with CFSE-labeled Fn, Pm, Ph, Ss and Ec at 
MOI 100 per cells for 6 and 24 hours. After fixation, the cells were stained 
with rhodamine-phalloidin and Hoechst 33342, and observed by confocal 
microscopy. The representative confocal images are shown (red: Actin fibers, 


















3.13. HSG cells remain viable after infection with selected oral bacteria   
Next, the viability of HSG cells was examined after infecting with Fn, Pm 
and Ss or a co-infection. Fn slightly decreased cells viability at 6 hour but 
not at 24 hours. Interestingly, Pm slightly decreased the cells viability at 6 
hours at MOI 50 in contrast the overall cells viability were increased after 24 
hours. Ss slightly decrease cells viability after 24 hours infection only at 
MOI 100. This result indicates that overall HSG cells remain viable after 




















Fig. 16 HSG cells viability did not change after infection with selected 
oral bacteria. HSG Cells viability was assessed at 6 and 24 hours post-
infection using Fn, Pm, Ss or a co-infection at MOI 50 and 100 using CCK-8 
assay. The representative data of four independent experiments are shown as 








3.14. Induction of chemokines and cytokines by oral bacteria 
Lymphocytic infiltration in salivary and lacrimal gland is the 
histopathological hall mark of SS pathology.  Overexpression of 
proinflammatory cytokine IL-6, BAFF, CXCL-10 and CXCL-13 has been 
reported in salivary glandular specimens from patients with primary SS. To 
test whether bacterial invasion into HSG cells effect the expression of 
cytokines and chemokines, mRNA level of IL-6, BAFF, CXCL-10 and 
CXCL-13 was examined. Fn significantly up-regulated the mRNA level of 
IL-6 and CXCL-10 while significance for BAFF mRNA expression was 
achieved only at early time point of 6 hours at MOI 100. Further, a co-
infection with Pm produced a synergistic effect on the production of CXCL-
10 mRNA expression. Pm only significantly increased BAFF mRNA level at 
early time point of 6 hours and MOI 50. The increased mRNA level of IL-6 








Fig. 17 Cytokines and chemokines were upregulated by selected oral bacteria 
in HSG cell.  The mRNA level of IL-6, CXCL-10, CXCL-13 and BAFF in HSG 
cells were determined at MOI 50 and 100 after 6 and 24 infection. The mean + SEM 
of four independent experiments, IL-6 and CXCL-10 RT-PCR data was further 




3.15. Oral bacteria can produce sicca symptoms in experimental animal 
model 
A number of preliminary animal experiments were performed to optimize the 
route and inoculum size of oral bacteria using C57BL/6 mice. In the final 
experiment, twenty mice were randomly divided into four groups; Sham, Fn, 
Pm and Fn-Pm groups, each mice was sublingually inoculated six times with 
2x10
9
 selected oral bacteria (four times at one week interval and two booster 
doses) and pilocarpine stimulated salivary flow rate was determined after 
infection at two weeks interval (Fig. 18A). C57BL/6 mice showed 
progressive decline in salivary flow rate in the first four weeks in response to 
oral inoculation of Fn, Fn-Pm and Pm respectively. Fn group showed 
decrease in salivary flow rate in the first four week, a co-inoculation of Fn 
and Pm showed early and consistent decrease in saliva, while Pm alone 
showed a mild effect. However once bacterial inoculation was stopped or 
delayed to 2 weeks, salivary flow rate returned to normal, Interestingly Fn-
Pm group showed consistent low salivary flow rate (Fig. 18A). To examine 
the extent of inflammation in salivary glands in response to oral bacterial 
inoculation, the mRNA level of proinflammatory cytokines IL6 and 
chemokines CXCL-10, CXCL-13 and BAFF was quantified by RT-PCR. 
Unexpectedly, IL-6, CXCL-10, CXCL-13 and BAFF were significantly 
downregulated by Pm. However, the effect of Fn are insignificant (Fig. 18B). 




expressing human AQP5. Human AQP5 is 91% identical to mouse AQP5 
and autoantibodies can cross react with human AQP5, one mice from Fn 
group and two mice from Pm group developed cross-reacting autoantibodies 
to human AQP5 (Fig. 18C). Mouse salivary glands were also stained with 
hematoxylin and eosin and anti-CD3 antibodies for histo-morphologic 
changes and lymphocytic infiltration. Only mild lymphocytic infiltrations 








Fig. 18 Evaluation of SS-like character in C57BL/6 mice salivary glands 
after bacteria inoculation into oral cavity. C57BL/6 mice were inoculated 
with selected oral bacteria and saliva flow rate was determined by 
stimulating with intraperitoneal injection of pilocarpine (5µg/g) for 3 min, 
then whole saliva was collected for next 7 min. The saliva flow rate was 
calculated as microliter per gram body weight (A). The mRNA expression of 




salivary glands after bacterial inoculation into the oral cavity, quantification 
was normalized to beta-actin and data were represented as mean + SEM of 
the results from five mice per group (B). Detection of anti-AQP5 
autoantibodies, cross reacting anti-AQP5 autoantibodies were detected by 
IIFA using MDCK cells overexpressing human AQP5 (C). C57BL/6 mice 
salivary glands were histologically examined by staining with hematoxylin 





















4.1 Autoantibodies to human AQP5 were detected in Sera from patients 
with SS 
The results of this study showed that autoantibodies against AQP5 are 
present in the sera of SS patients. Furthermore, patients with anti-AQP5 
autoantibodies presented significantly lower resting salivary flow than those 
without the anti-AQP5 antibodies. This is the first report on the association 
between anti-AQP5 autoantibodies and SS.  Like other AQPs, AQP5 
consists of six transmembrane alpha-helixes connected by five loops, and the 
protein forms a water channel as narrow as 1-4 Å through the plasma 
membrane (Horsefield et al., 2008). If antibodies bind to the extracellular 
loops of AQP5, the antibodies may block the passage of water molecules 
through the channel. AQP5 is mainly localized to the apical membrane of 
acinar cells and intercalated ducts. AQP5 has also been found at the 
basolateral membrane of acinar cells in the mouse salivary glands (Larsen et 
al., 2011). However, the basolateral localization of AQP5 in normal human 
salivary glands has not been reported yet. Although dyslocalization of AQP5 
from the apical to the basolateral sites of acinar cells in SS patients has been 
reported by two groups, the other two groups reported no difference in the 
subcellular localization of AQP5 between the normal and SS salivary glands 





AQP5 located on the basolateral side can be accessed by anti-AQP5 
autoantibodies present in the tissue fluid, while AQP5 present on the apical 
side of acinar cells can be accessed by anti-AQP5 autoantibodies present in 
saliva. Unexpectedly, the anti-AQP5 autoantibodies were also detected in the 
sera of many HC at low levels. Highly conserved AQPs are distributed 
throughout all the kingdoms of life, including bacteria. It has been shown 
that mouse immune serum rose against E. coli AQPZ react with human 
AQP4 (Ren et al., 2012). 
When the bacterial protein database was BLAST-searched using the 
human AQP5 sequence as a query, AQPZ or porins from many human-
associated bacteria had a high degree of homology with human AQP5 or 
AQP1. Therefore, there is a possibility that the autoantibodies against human 
AQP5 were developed during an immune response against bacterial proteins. 
While IIFA showed a clear difference in the levels of anti-AQP5 
autoantibodies between the control and SS sera, and specifically detected 
anti-AQP1 autoantibodies in sera from patients with SS, 
immunoprecipitation was not effective in differentiating the control and 
patient samples. This discrepancy could be attributed to potential differences 
in the conformations and exposed epitopes present in membrane versus 
lysates. In this regard, the anti-AQP5 autoantibodies detected in the control 




AQP5. Unfortunately, the salivary flow rates were available only for 10 
control subjects, and the effect of the anti-AQP5 autoantibodies on salivary 
flow in the control group could not be evaluated. One of the limitations of 
the current study is a relatively small sample size. Therefore, further studies 
using samples from larger SS patient cohorts and diverse control subjects, 
including other autoimmune diseases, are needed.  
The presence of anti-Ro/SSA and/or anti-La/SSB autoantibodies in 
serum is a diagnostic hallmark of SS (Lennon et al., 2004). A number of 
other autoantibodies such as anti-salivary gland protein 1, anti-carbonic 
anhydrase 6, anti-parotid secretory protein, anti-α-fodrin, anti-M3R, anti-
nuclear and anti-smooth muscle antibodies have been identified in SS 
(Bournia & Vlachoyiannopoulos, 2012; Lee et al., 2013; Shen et al., 2012). 
Except for the anti-parotid secretory protein and anti-M3R antibodies, most 
autoantibodies target antigens that are normally present inside cells. 
Therefore, those autoantibodies reflect the apoptotic destruction of gland 
tissues, that is, a result of the disease process rather than the cause of the 
disease (Smith & Dawson, 2012). The degree of salivary dysfunction in SS 
patients does not correlate with the degree of glandular tissue destruction 
(Koo et al., 2008). Indeed, the presence of either anti-Ro or anti-La 





In contrast, anti-M3R autoantibodies have the potential to interfere 
with the secretory process by inhibiting signaling through M3R and AQP5 
translocation (Dawson et al., 2006; Koo et al., 2008; Lee et al., 2013). The 
binding of autoantibodies to M3R also down-regulates the receptors from the 
plasma membrane by inducing internalization (Jin et al., 2012). However, the 
functional data have not been reconciled with the sensitivity and specificity 
of the anti-M3R autoantibodies in screening trials (Smith & Dawson, 2012). 
Although anti-M3R autoantibodies have been detected in 9 to 100% of SS 
patients depending on the method and antigens used (Sumida et al., 2014), a 
recent meta-analysis study concluded that the anti-M3R antibody has high 
specificity (0.95) but relatively low sensitivity (0.43) to diagnose SS (Deng 
et al., 2015). In this aspect, the anti-AQP5 autoantibodies identified in the 
current study could complement anti-M3R autoantibodies.  
In conclusion, anti-AQP5 and anti-AQP1 autoantibodies were 
detected in the sera of SS patients, which could be a novel biomarker of SS 
and provide new insight into the pathogenesis of SS. In addition, association 
between the presence of anti-AQP5 autoantibodies and resting salivary flow 







4.2 The presence of anti-AQP1 autoantibodies was not associated with 
salivary flow rate 
Herein, we reported the presence of serum autoantibodies against AQP1 in 
some patients with SS. The frequency of anti-AQP1 IgG or IgA (27.4%) 
detected in SS patients in the current study was higher than that of the anti-
AQP1 autoantibodies reported in patients with suspected neuromyelitis 
optica spectrum disorders (Tzartos et al., 2013). In contrast to anti-AQP5 
autoantibodies, for which the presence of anti-AQP5 IgA had overlapped 
with the presence of anti-AQP5 IgG, the presence of anti-AQP1 IgA 
coincided with the presence of anti-AQP5 IgA, rather than the presence of 
anti-AQP1 IgG. Similarly, the presence of anti-AQP1 IgG overlapped with 
the presence of anti-AQP5 IgG. Therefore, anti-AQP1 autoantibodies are 
likely to be a byproduct of an antibody response to AQP5. A significant 
positive correlation between the intensities of the two autoantibodies 
supports it. The amino acid sequence of AQP1 has 44% identity and 62% 
similarity with AQP5. In contrast to AQP5 in which the full lengths of loops 
B and E are exposed to the cytosolic and extracellular compartments, 
respectively, the middle portion of loops B and E in AQP1 is embedded 
within the membrane (Figure 9B).  However, short stretches of conserved 
sequences were observed in loop B, loop D, and loop E, as well as the C-




Interestingly, anti-AQP1 autoantibodies were not detected in any control sera, 
although 32.1% of them were positive for anti-AQP5 IgG.  
Two-thirds of the anti-AQP1 autoantibodies detected in patients with 
suspected neuromyelitis optica spectrum disorders were bound to the 
extracellular domain of AQP1 (Tzartos et al., 2013). If the anti-AQP1 
autoantibodies detected in SS patients bind to the AQP1 expressed on 
myoepithelial cells and endothelial cells in-vivo, antibodies may block water 
flow across these cells, interfering with the inflow of water to the acini. 
However, the presence of anti-AQP1 autoantibodies did not affect either 
resting or stimulated salivary flow. This supports the notion that AQP1 does 
not play a major role in salivary secretion, as observed in AQP1-deficient 
mice (Delporte et al., 2016). The increase in salivary flow observed in SS 
patients after B-cell depletion may be attributed to the elimination of other 
autoantibodies, such as anti-M3R or anti-AQP5 autoantibodies. 
In conclusion, anti-AQP1 autoantibodies were detected in some SS 
patients. Although anti-AQP1 autoantibodies are not useful as a diagnostic 
marker because of their low sensitivity, the presence of autoantibodies to 






4.3 Epitope mapping of anti-AQP5 autoantibodies in the sera of SS 
patients  
The result of this study showed that synthetic peptides corresponding to the 
extracellular loops of AQP5 neutralized anti-AQP5 autoantibodies in the sera 
of patients with SS but not those in control sera. Synthetic peptides have 
been used previously to determine the specificity of autoantibodies found in 
different autoimmune diseases, including anti-AQP4 (Kampylafka et al., 
2011), anti-citrullinated -enolase (Lundberg et al., 2008), anti-Ro (Frank et 
al., 1994; Routsias et al., 1996), anti-La (Tzioufas et al., 1997) and anti-T 
cell receptors (Landsperger et al., 1997). Screening anti-AQP5 IgG positive 
sera against these peptides revealed that IgG from SS patients were 
significantly neutralized by synthetic peptides, while control sera showed 
minimal reactivity. Although anti-AQP5 autoantibodies were present in both 
SS and control sera, this high reactivity of IgG from SS with synthetic 
peptides could be attributed to the antibodies in the control sera recognize 
epitopes in the helix or cytoplasmic loops. The highest inhibition was 
achieved by epitopes targeting loop-C in 9 samples and peptides targeting 
loop-E in 9 samples. Interestingly IgG from 6 SS patients (24%) recognized 
none of the synthetic peptides. No reactivity was found with irrelevant 
peptides (IRP). Although loop-C was probably the most strong epitope, 
autoantibodies to loop-E which make the pore for the transportation of water 




4.4 Dysbiosis of oral microbiota occurs in dry mouth condition  
Pyrosequencing data revealed drastic changes in the bacterial communities 
associated with the dryness of mouth, although the bacterial communities of 
SC and SS were similar to each other, the relative abundance of 
species/phylotypes were different between SC and SS. The predominant 
taxas detected in HC in this study belonged to Firmicutes, Proteobacteria, 
Actinobacteria, Bacteroidetes, and Fusobacteria was consistent with the 
previous reports (Crielaard et al., 2011; Huang et al., 2011; Zaura et al., 
2009). When oral microbiota were compared at the phylum level, Firmicutes 
and Actinobacteria, two of the predominant phyla, were significantly more 
abundant in microbiota associated with dryness of mouth, while the 
proportion of Proteobacteria and Fusobacteria were significantly decreased. 
At genus level, Streptococcus, Rothia and lactobacillus were significantly 
increased in both SC and SS, whereas Neisseria, Haemophillus, 
Fusobacterium, Porphyromonas, and Leptotrichia along with other minor 
generas were significantly decreased in both SC and SS (Tab. 7). The 
decrease in Fusobacterium was unexpected in this study; however some 
previous reports suggested that Fusobacterium are more sensitivity to acidic 
milieu (Almstah et al., 2003; Bradshaw et al., 1989; Kuru et al., 2002; Leung 




At species level, comparison of relative abundance between HC, SC 
and SS were performed. Among the 70 species significantly changed in 
relative proportion in dry mouth, members of the normal flora or bacteria 
associated with oral health was significantly decreased in relative abundance 
in both SC and SS which include H. parainfluenzae, N. subflava, N. 
perflava, S. sanguinis, Lautropia mirabilis, Campylobacter concisus 
(Takeshita et al., 2009). In contrast a heterogeneous group of bacteria 
belongs to streptococcus, Rothia mucilaginosa and Rothia dentocariosa was 
significantly increased in dry mouth, while Prevotella histicola was 
specifically increased in SS (Table 6). The increase in streptococcus species 
in xerostomia could be due to lower pH buffer capacity associated with 
hyposalivation resulted in increased acid tolerant strain predominating the 
acid sensitive strains (Hayashi et al., 2015). Dysbiosis of oral microbiota has 
been characterized by the higher proportion of Prevotella and Veillonella and 
lower proportion of Streptococcus, Neisseria, Haemophilus and Gemella 
(Said et al., 2014). Current reports proposed a potential link between the 
Prevotella species and autoimmune diseases e.g. transmissible 
autoinflammation in murine intestine and rheumatic arthritis (Elinav et al., 
2011; Scher et al., 2013; Scher et al., 2012). The strong female predominance 
especially in the postmenopausal women and the results from many animal 




al., 2009; Ishimaru et al., 2003; Ishimaru et al., 1999; Konttinen et al., 2012). 
Looijer et al. demonstrated reduced estrogen receptor mRNA expression and 
increased gut permeability (Looijer-van et al., 2011). Defect in epithelial 
barrier function trigger exocrine gland dysfunction and global immune 
activation (Yin et al., 2014).  AQPS are the major water channel proteins 
expressed in the lacrimal and salivary glands, and have a critical role in tear 
and saliva secretion. Highly conserved AQPs are distributed throughout all 
the kingdoms of life, including bacteria. A multi sequence alignment of 
AQPs/porins from human and major species of oral microbiota confirmed 
high degree of homology. Considering changes in the oral microbiota 
composition and defects in epithelial barrier function, there is a possibility 
that cross reacting autoantibodies could develop against human AQP5 and 
AQP1 during an immune response to oral microbiota. However, when 
control and SS sera were screened for the presence of antibodies to 
commensal oral bacteria using whole bacteria cell lysate from Ss, Rm, Ph 
and Pm, no significant difference was found in serum antibodies level to 
commensal bacteria between HC and SS patient except for Rm where the 
anti-Rm serum antibodies level was significantly decreased in SS. No 
association was found between the presence of auto-antibodies to AQP5/1 
and high titer of serum antibodies level to commensal bacteria. But in other 




actinomycetemcomitans, P. gingivalis and P. denticola in patient with SS 
(Celenligil et al., 1998; Lugonja et al., 2016). Moreover, It has been shown 
that mouse immune serum rose against E. coli AQPZ react with human 
AQP4 (Ren et al., 2012). B cell epitope analysis showed the presence of 
conserved linear epitope in the extracellular loops which supports the notion 
that the extracellular loops may be the targets of cross reacting 
autoantibodies produced against bacterial proteins, and AQP5 and AQP1 as 














4.5 Oral bacteria produced sicca symptoms in experimental animal 
The present study demonstrated that Fn upregulated proinflammatory 
cytokine IL-6 and chemokine CXCL-10 from HSG cell and produced sicca 
symptoms in experimental mice model. SS has been characterized by 
lymphocytic infiltration and increased level of proinflammatory cytokines 
and chemokines (Hernandez-Molina et al., 2011; Moriyama et al., 2012; 
Tishler et al., 1999). Previously, viral DNA has been detected from salivary 
gland biopsies from patient with SS as a potential triggering agent, the role 
of oral bacteria in the pathogenesis of SS are not reported (Fox et al., 1986; 
Jeffers & Webster-Cyriaque, 2011; Saito et al., 1989). Several animal models 
confirmed the phenomenon of bacterial invasion followed by lymphocytic 
infiltration during disease process (Van et al., 2002). Defect in epithelial 
barrier function in SS could allow increased paracellular invasion of oral 
bacteria into tissues and persistent chronic inflammation. Indeed, bacteria 
will first encounter underlying tissues and immune cells, the effect of oral 
bacteria on salivary gland cells cannot be ignored. In this study we found that 
Fn and Pm efficiently invaded into HSG cells; further, Fn significantly 
upregulated the IL-6 and CXCL-10 in in-vitro condition. This observation 
suggested that Fn and Pm could effectively attract macrophages, T and B 
lymphocytes into the salivary glands. In experimental mice model, C57BL/6 




in response to oral bacterial inoculation, however once the bacterial 
inoculation was stopped saliva flow return to normal, interestingly Fn-Pm 
group showed a consistent decrease in salivary flow rate throughout 
experiment. Salivary glands dysfunction as a result of bacterial infection has 
been previously reported in acute sialadenitis (Raad et al., 1990). Fn and Pm 
was isolated from blood culture of patients with acute salivary glands 
infection (Anthes et al., 1981; Brook, 2003). Sicca symptoms observed in the 
current study could be due to the fact that both Fn and Pm are gram negative 
bacteria and capable to invade into HSG cells, releasing bioactive bacterial 
components such as LPS could induce downregulation of AQP5 mRNA 
(Yao et al., 2010) and alteration in tight junction (Wang et al., 2016). To 
investigate the other possible underline mechanisms of salivary gland 
dysfunction, all mice were killed eight weeks after the first bacterial 
inoculation and mRNA level of proinflammatory cytokines and chemokines 
were quantified in salivary glands. Unexpectedly, Pm significantly down 
regulated IL-6, CXCL-10, CXCL-13 and BAFF. Mild lymphocytic 
infiltration was seen in all infected groups. Further, anti-AQP5 
autoantibodies were detected in two mice from Pm and one mouse from Fn 
group. However, the presence of autoantibodies to AQP5 did not affect 




This study has a limitation of using wild type mice, SS is a 
multifactorial autoimmune disease; both environmental and hormonal factors 
trigger exocrinopathy in individuals with genetic predisposition. To include 
the genetic basis of disease pathogenesis and disrupted epithelial barrier 
function; further study requires the use of knockout mice e.g. C57BL6 IκBζ-
/- and B6.129S4-Id3tm1Zhu.  
Although in this study we showed that selected oral bacteria Fn and 
Pm are capable to invade into HSG cells and produce sicca symptoms in 
experimental mice model. The exact role of these bacteria in the recruitment 
of lymphocytes, productions of autoantibodies, and salivary gland 
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쇼그렌증후군의 병인에서 아쿠아포린 5 및 아쿠아포린 1와 대한 자가항
체와 구강세균총의 잠재적인 역할 
 
Jehan Alam  
분자면역학 및 미생물학 전공 
치의과학과, 서울대학교 치의학대학원 
배경  
쇼그렌 증후군은 침샘과 눈물샘을 주요 표적으로 삼아 눈과 구강의 건
조증을 유발하는 자가면역질환이다. 아쿠아포린은 동식물뿐만 아니라 
세균과 원시세균에서 발현되는 작은 소수성 막관통 물채널 단백질이다. 
인간의 침샘에서 아쿠아포린 5 (AQP5)와 아쿠아포린 1 (AQP1)의 
mRNA 및 단백질 발현은 많은 연구에 의해 확인되었다. AQP1의 발현은 
모세혈관 내피세피 및 근상피세포에 집중된 반면 AQP5는 눈물샘과 침
샘의 포상세포와 개재도관에서 발현된다. 쥐에서 AQP5가 결손 되면 용




는 타액 생산에 중요한 역할을 한다. 일부 구강세균의 아쿠아포린 또는 
포린은 인간의 아쿠아포린과 높은 상동성을 보이고 있다. B 세포 항원결
정부 예측 분석에 의하면 인간의 AQP5 및 AQP1과 세균 아쿠아포린의 
세포외 루프에 진화적으로 보존된 선형 항원결정부가 존재해 세균 아쿠
아포린을 표적으로 생성된 항체가 인간의 AQP5 및 1의 세포외 루프에 
교차반응 해 물 분자의 진입을 차단할 가능성을 제시하였다. 또한 세균
총의 부조화가 여러 자가면역질환을 유도할 수 있음이 여러 연구에서 
보고되었다. 그러나 쇼그렌 증후군의 병인에서 구강세균총의 역할은 
잘 알려지지 않았다. 이에 따라 본 연구의 목적은 쇼그렌 증후군의 병인
에 있어서 인간 AQP5 및 아쿠아포린 1에 대한 자가항체와 구강 세균총
의 잠재적인 역할을 연구하는 것이다.  
재료 및 방법 
원발성 쇼그렌 증후군 환자 혈청에서 항-AQP5/1 자가항체를 간접 면역
형광분석법으로 검출하기 위해 마우스 턱밑 침샘의 동결 절편, 인간 
AQP5-GFP 융합 단백질 또는 GFP를 발현하는 CHO 세포, 그리고 AQP5 




단백질 또는 GFP를 과발현하는 HEK-293 세포의 용해물질을 면역 침강
에 사용했다. 또한, 인간 AQP5 세포 외 루프에 대응하는 합성 펩티드를 
이용해 항-AQP5 자가항체에 대한 AQP5의 에피토프를 결정하였다. 건
강한 대조군, 건조증 대조군으로 약물로 인한 구강건조증 환자, 그리고 
쇼그렌 증후군 환자에서 구강세균을 수집해 세균 커뮤니티를 파이로시
퀀싱으로 분석했다. 인간 침샘 (HSG) 세포를 선택한 구강세균과 함께 
배양한 후 세균의 HSG 세포 침투와 HSG 세포에서 사이토카인 및 케모
카인 발현을 관찰하였다. C57BL/6 마우스를 무작위로 대조군, Fn, Pm 
및 Fn-Pm 4 그룹 (그룹 당 5 마리)으로 나누고, Fn, Pm 및 Fn-Pm 그룹은 
각기 6 회에 걸쳐 2 × 109 세포의 Fusobacterium nucleatum, Prevotella 
melaninogenica, F. nucleatum+P. melaninogenic 세균을 설하에 투여 받았
다. 각 마우스에 대해 2 주 간격으로 필로카핀에 의한 타액분비량을 측
정하였고 8 주 차에 턱밑 침샘과 혈청을 수집해 사이토카인, 케모카인 
발현 분석, 조직병리학적 관찰, 그리고 항-AQP5 자가항체 검출을 수행
하였다. 
결과 
마우스 침샘의 포상세포에서 건강한 대조군의 혈청과는 달리 쇼그렌 




염색과 중첩함을 확인하였다. AQP5-GFP를 발현하는 CHO에서도 환자 
혈청의 IgG에 의한 염색이 GFP와 중첩함을 확인하였다. 그러나 대조군
과 쇼그렌 증후군 환자 모두 혈청내 IgG가 AQP5-GFP를 면역침강 하였
다. 따라서 대조군의 혈청에도 AQP5에 대한 자가항체가 존재함을 알 
수 있었다. AQP5를 과발현 하는 MDCK 세포를 이용한 간접 면역형광
분석법으로 대조군 53 명과 쇼그렌 증후군 환자 112 명의 혈청을 검사
했을 때 환자군에서 항-AQP5 IgG 자가항체가 유의하게 높은 수준으로 
검출되었고, 검사는 0.73의 감도와 0.68 특이성을 보였다. 항-AQP1 자가
항체는 16.07%의 쇼그렌 증후군에서만 발견되었다. 또한 항-AQP5 자가
항체의 존재가 쇼그렌 증후군 환자에서 낮은 비자극 타액 분비율과 유
의한 연관을 보인 것과 달리 항-AQP1 자가항체의 유무는 타액 분비율
과 연관이 없었다. AQP5 세포 외 루프에 대응하는 합성 펩티드는 쇼그
렌 증후군 환자 혈청의 항-AQP5 자가항체가 AQP5에 결합하는 것을 크
게 억제하였다. 구강세균총 분석 결과 구강건조증과 연관된 것으로 보
이는 큰 변화가 관찰되었다. 구강건조증 대조군과 쇼그렌 증후군 환자
의 세균 군집이 서로 비슷했지만, ~ 종/phylotypes에서는 두 그룹 간에 상
대적인 양의 유의한 차이를 보였다. 로지스틱 회귀 분석 결과 P. 
melaninogenica의 증가가 쇼그렌 증후군 위험 (OR 5.396/1% 증가, 95% 




성을 갖는 포린 단백질을 갖고 있고 F. nucleatum은 알려진 구강세균 종 
중 높은 침투 능력을 가지고 있기 때문에 두 세균종을 세포 실험 및 동
물 실험을 위해 선택하였다. HSG 세포는 F. nucleatum에 대한 반응으로 
용량 의존적인 양식으로 염증성 사이토카인 IL-6와 케모카인 CXCL-10
을 생성하였으나 P. melaninogenica은 그러한 반응을 유도하지 않았다. 
또한 C57BL/6 마우스에 F. nucleatum과 P. melaninogenica를 설하 접종 
했을 때 일부 마우스에서 침샘에 T 세포의 약한 침윤을 동반하는 쇼그
렌 증후군-유사 증상이 관찰되었다. 
결론  
결론적으로, AQP5에 대한 자가항체와 구강세균총의 변화가 쇼그렌 증
후군의 병인에 기여할 가능성이 있다. 쇼그렌 증후군 환자의 혈청에서 
검출된 항-AQP5 자가항체는 쇼그렌 증후군의 신규 생체표지자가 될 수 
있으며 질병의 병인에 새로운 통찰을 제공할 것이다. 
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